☰

Marilyn S. Albert, PhD - Publications

Affiliations: 
Neurology Johns Hopkins University, Baltimore, MD 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=39
Website:
http://www.alzresearch.org/team.cfm?ID=3
Tree Info Grants Similar researchers PubMed Report error

409 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Mohs R, Bakker A, Rosenzweig-Lipson S, Rosenblum M, Barton RL, Albert MS, Cohen S, Zeger S, Gallagher M. The HOPE4MCI study: A randomized double-blind assessment of AGB101 for the treatment of MCI due to AD. Alzheimer's & Dementia (New York, N. Y.). 10: e12446. PMID 38356475 DOI: 10.1002/trc2.12446  0.378
2023 Rani N, Alm KH, Corona-Long CA, Speck CL, Soldan A, Pettigrew C, Zhu Y, Albert M, Bakker A. Tau PET burden in Brodmann areas 35 and 36 is associated with individual differences in cognition in non-demented older adults. Frontiers in Aging Neuroscience. 15: 1272946. PMID 38161595 DOI: 10.3389/fnagi.2023.1272946  0.324
2023 Bahrani AA, Abner EL, DeCarli CS, Barber JM, Sutton AC, Maillard P, Sandoval F, Arfanakis K, Yang YC, Evia AM, Schneider JA, Habes M, Franklin CG, Seshadri S, Satizabal CL, ... ... Albert MS, et al. Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol. Journal of Alzheimer's Disease : Jad. PMID 37840499 DOI: 10.3233/JAD-230629  0.311
2023 Sun Y, Moghekar A, Soldan A, Pettigrew C, Greenberg B, Albert M, Wang MC. Cerebrospinal Fluid Alzheimer's Disease Biomarker Patterns of Change Prior to the Onset of Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 37742656 DOI: 10.3233/JAD-230807  0.348
2023 Kamalian A, Ho SG, Patel M, Lewis A, Bakker A, Albert M, O'Brien RJ, Moghekar A, Lutz MW. Exploratory Assessment of Proteomic Network Changes in Cerebrospinal Fluid of Mild Cognitive Impairment Patients: A Pilot Study. Biomolecules. 13. PMID 37509130 DOI: 10.3390/biom13071094  0.326
2023 Rajabli F, Benchek P, Tosto G, Kushch N, Sha J, Bazemore K, Zhu C, Lee WP, Haut J, Hamilton-Nelson KL, Wheeler NR, Zhao Y, Farrell JJ, Grunin MA, Leung YY, ... ... Albert MS, et al. Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies and nominates ancestry-specific loci , , and as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics Consortium. Medrxiv : the Preprint Server For Health Sciences. PMID 37461624 DOI: 10.1101/2023.07.06.23292311  0.458
2023 Soldan A, Oh S, Ryu T, Pettigrew C, Zhu Y, Moghekar A, Xiao MF, Pontone GM, Albert M, Na CH, Worley P. NPTX2 in cerebrospinal fluid predicts the progression from normal cognition to Mild Cognitive Impairment. Annals of Neurology. PMID 37345460 DOI: 10.1002/ana.26725  0.326
2023 Pettigrew C, Nazarovs J, Soldan A, Singh V, Wang J, Hohman T, Dumitrescu L, Libby J, Kunkle B, Gross AL, Johnson S, Lu Q, Engelman C, Masters CL, Maruff P, ... ... Albert M, et al. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals. Alzheimer's Research & Therapy. 15: 66. PMID 36978190 DOI: 10.1186/s13195-023-01206-9  0.321
2023 Stouffer KM, Chen C, Kulason S, Xu E, Witter MP, Ceritoglu C, Albert MS, Mori S, Troncoso J, Tward DJ, Miller MI. Early amygdala and ERC atrophy linked to 3D reconstruction of rostral neurofibrillary tau tangle pathology in Alzheimer's disease. Neuroimage. Clinical. 38: 103374. PMID 36934675 DOI: 10.1016/j.nicl.2023.103374  0.348
2023 Newton P, Tchounguen J, Pettigrew C, Lim C, Lin Z, Lu H, Moghekar A, Albert M, Soldan A. Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 36744337 DOI: 10.3233/JAD-220846  0.39
2022 Pettigrew C, Soldan A, Wang J, Wang MC, Greenberg B, Albert M, Moghekar A. Longitudinal CSF Alzheimer's disease biomarker changes from middle age to late adulthood. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12374. PMID 36415591 DOI: 10.1002/dad2.12374  0.351
2022 Greenberg BD, Pettigrew C, Soldan A, Wang J, Wang MC, Darrow JA, Albert MS, Moghekar A. CSF Alzheimer Disease Biomarkers: Time-Varying Relationships With MCI Symptom Onset and Associations With Age, Sex, and . Neurology. 99: e1640-e1650. PMID 36216518 DOI: 10.1212/WNL.0000000000200953  0.339
2022 Luo J, Agboola F, Grant E, Morris JC, Masters CL, Albert MS, Johnson SC, McDade EM, Fagan AM, Benzinger TLS, Hassenstab J, Bateman RJ, Perrin RJ, Wang G, Li Y, et al. Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan. Brain : a Journal of Neurology. PMID 35925685 DOI: 10.1093/brain/awac238  0.363
2022 Hwang G, Abdulkadir A, Erus G, Habes M, Pomponio R, Shou H, Doshi J, Mamourian E, Rashid T, Bilgel M, Fan Y, Sotiras A, Srinivasan D, Morris JC, Albert MS, et al. Disentangling Alzheimer's disease neurodegeneration from typical brain ageing using machine learning. Brain Communications. 4: fcac117. PMID 35611306 DOI: 10.1093/braincomms/fcac117  0.361
2021 Pettigrew C, Soldan A, Brichko R, Zhu Y, Wang MC, Kutten K, Bilgel M, Mori S, Miller MI, Albert M. Computerized paired associate learning performance and imaging biomarkers in older adults without dementia. Brain Imaging and Behavior. PMID 34686968 DOI: 10.1007/s11682-021-00583-9  0.321
2021 Byeon SK, Madugundu AK, Jain AP, Bhat FA, Jung JH, Renuse S, Darrow J, Bakker A, Albert M, Moghekar A, Pandey A. Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease. Molecular Omics. 17: 454-463. PMID 34125126 DOI: 10.1039/d0mo00186d  0.318
2021 Wilcock D, Jicha G, Blacker D, Albert MS, D'Orazio LM, Elahi FM, Fornage M, Hinman JD, Knoefel J, Kramer J, Kryscio RJ, Lamar M, Moghekar A, Prestopnik J, Ringman JM, et al. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33480172 DOI: 10.1002/alz.12215  0.305
2020 Chan CK, Soldan A, Pettigrew C, Wang J, Albert M, Rosenberg PB. Depressive symptoms and CSF Alzheimer's disease biomarkers in relation to clinical symptom onset of mild cognitive impairment. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12106. PMID 33005725 DOI: 10.1002/dad2.12106  0.32
2020 Pettigrew C, Soldan A, Wang J, Wang MC, Arthur K, Moghekar A, Gottesman RF, Albert M. Association of midlife vascular risk and AD biomarkers with subsequent cognitive decline. Neurology. PMID 32989109 DOI: 10.1212/WNL.0000000000010946  0.302
2020 Kulason S, Xu E, Tward DJ, Bakker A, Albert M, Younes L, Miller MI. Entorhinal and Transentorhinal Atrophy in Preclinical Alzheimer's Disease. Frontiers in Neuroscience. 14: 804. PMID 32973425 DOI: 10.3389/Fnins.2020.00804  0.388
2020 Habes M, Pomponio R, Shou H, Doshi J, Mamourian E, Erus G, Nasrallah I, Launer LJ, Rashid T, Bilgel M, Fan Y, Toledo JB, Yaffe K, Sotiras A, Srinivasan D, ... ... Albert MS, et al. The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32920988 DOI: 10.1002/Alz.12178  0.43
2020 Luo J, Agboola F, Grant E, Masters CL, Albert MS, Johnson SC, McDade EM, Vöglein J, Fagan AM, Benzinger T, Massoumzadeh P, Hassenstab J, Bateman RJ, Morris JC, Perrin RJ, et al. Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study. Neurology. PMID 32873693 DOI: 10.1212/Wnl.0000000000010747  0.455
2020 Soldan A, Pettigrew C, Zhu Y, Wang MC, Gottesman RF, DeCarli C, Albert M. Cognitive reserve and midlife vascular risk: Cognitive and clinical outcomes. Annals of Clinical and Translational Neurology. 7: 1307-1317. PMID 32856790 DOI: 10.1002/Acn3.51120  0.371
2020 Wang Z, Tang Z, Zhu Y, Pettigrew C, Soldan A, Gross A, Albert M. AD risk score for the early phases of disease based on unsupervised machine learning. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32729964 DOI: 10.1002/Alz.12140  0.426
2020 Sur S, Lin Z, Li Y, Yasar S, Rosenberg P, Moghekar A, Hou X, Kalyani R, Hazel K, Pottanat G, Xu C, van Zijl P, Pillai J, Liu P, Albert M, et al. Association of cerebrovascular reactivity and Alzheimer pathologic markers with cognitive performance. Neurology. PMID 32661101 DOI: 10.1212/Wnl.0000000000010133  0.465
2020 Sathe G, Albert M, Darrow J, Saito A, Troncoso J, Pandey A, Moghekar A. Quantitative proteomic analysis of the frontal cortex in Alzheimer's disease. Journal of Neurochemistry. PMID 32614981 DOI: 10.1111/Jnc.15116  0.386
2020 Bashyam VM, Erus G, Doshi J, Habes M, Nasralah I, Truelove-Hill M, Srinivasan D, Mamourian L, Pomponio R, Fan Y, Launer LJ, Masters CL, Maruff P, Zhuo C, Völzke H, ... ... Albert MS, et al. MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14 468 individuals worldwide. Brain : a Journal of Neurology. PMID 32591831 DOI: 10.1093/Brain/Awaa160  0.309
2020 Raghavan NS, Dumitrescu L, Mormino E, Mahoney ER, Lee AJ, Gao Y, Bilgel M, Goldstein D, Harrison T, Engelman CD, Saykin AJ, Whelan CD, Liu JZ, Jagust W, Albert M, et al. Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease. Jama Neurology. PMID 32568366 DOI: 10.1001/Jamaneurol.2020.1760  0.491
2020 Jiang D, Lin Z, Liu P, Sur S, Xu C, Hazel K, Pottanat G, Darrow J, Pillai JJ, Yasar S, Rosenberg P, Moghekar A, Albert M, Lu H. Brain Oxygen Extraction Is Differentially Altered by Alzheimer's and Vascular Diseases. Journal of Magnetic Resonance Imaging : Jmri. PMID 32567195 DOI: 10.1002/Jmri.27264  0.441
2020 Cable J, Holtzman DM, Hyman BT, Tansey MG, Colonna M, Kellis M, Brinton RD, Albert M, Wellington CL, Sisodia SS, Tanzi RE. Alternatives to amyloid for Alzheimer's disease therapies-a symposium report. Annals of the New York Academy of Sciences. PMID 32472577 DOI: 10.1111/Nyas.14371  0.388
2020 Soldan A, Pettigrew C, Albert M. Cognitive Reserve from the Perspective of Preclinical Alzheimer Disease: 2020 Update. Clinics in Geriatric Medicine. 36: 247-263. PMID 32222300 DOI: 10.1016/J.Cger.2019.11.006  0.436
2020 Koychev I, Vaci N, Bilgel M, An Y, Muniz GT, Wong DF, Gallacher J, Mogekhar A, Albert M, Resnick SM. Prediction of rapid amyloid and phospotylated-Tau accumulation in cognitively healthy individuals. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12019. PMID 32211504 DOI: 10.1002/Dad2.12019  0.458
2020 Sathe G, Mangalaparthi KK, Jain A, Darrow J, Troncoso J, Albert M, Moghekar A, Pandey A. Multiplexed Phosphoproteomic Study of Brain in Patients with Alzheimer's Disease and Age-Matched Cognitively Healthy Controls. Omics : a Journal of Integrative Biology. PMID 32182160 DOI: 10.1089/Omi.2019.0191  0.427
2020 Allnutt MA, Johnson K, Bennett DA, Connor SM, Troncoso JC, Pletnikova O, Albert MS, Resnick SM, Scholz SW, De Jager PL, Jacobson S. Human Herpesvirus 6 Detection in Alzheimer's Disease Cases and Controls across Multiple Cohorts. Neuron. PMID 31983538 DOI: 10.1016/J.Neuron.2019.12.031  0.365
2020 Walker KA, Gross AL, Moghekar AR, Soldan A, Pettigrew C, Hou X, Lu H, Alfini AJ, Bilgel M, Miller MI, Albert MS, Walston J. Association of peripheral inflammatory markers with connectivity in large-scale functional brain networks of non-demented older adults. Brain, Behavior, and Immunity. PMID 31935468 DOI: 10.1016/J.Bbi.2020.01.006  0.377
2020 Xiong C, Luo J, Masters CL, Johnson SC, Albert MS, McDade E, Fagan AM, Benzinger TL, Hassenstab J, Cruchaga C, Bateman RJ, Morris JC. Orderings of biomarker changes for Alzheimer disease in cognitively normal individuals from 18 to 101 years of age Alzheimer's & Dementia. 16. DOI: 10.1002/alz.043187  0.323
2019 Pettigrew C, Soldan A, Zhu Y, Cai Q, Wang MC, Moghekar A, Miller MI, Singh B, Martinez O, Fletcher E, DeCarli C, Albert M. Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals. Neurobiology of Aging. PMID 31932050 DOI: 10.1016/J.Neurobiolaging.2019.12.003  0.444
2019 Soldan A, Pettigrew C, Zhu Y, Wang MC, Moghekar A, Gottesman RF, Singh B, Martinez O, Fletcher E, DeCarli C, Albert M. White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease. Neurology. PMID 31888969 DOI: 10.1212/Wnl.0000000000008864  0.483
2019 Alm KH, Faria AV, Moghekar A, Pettigrew C, Soldan A, Mori S, Albert M, Bakker A. Medial temporal lobe white matter pathway variability is associated with individual differences in episodic memory in cognitively normal older adults. Neurobiology of Aging. PMID 31874745 DOI: 10.1016/J.Neurobiolaging.2019.11.011  0.397
2019 Blauwendraat C, Reed X, Krohn L, Heilbron K, Bandres-Ciga S, Tan M, Gibbs JR, Hernandez DG, Kumaran R, Langston R, Bonet-Ponce L, Alcalay RN, Hassin-Baer S, Greenbaum L, Iwaki H, ... ... Albert MS, et al. Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia. Brain : a Journal of Neurology. PMID 31755958 DOI: 10.1093/Brain/Awz350  0.338
2019 Hou X, Liu P, Li Y, Jiang D, De Vis JB, Lin Z, Sur S, Baker Z, Mao D, Ravi H, Rodrigue K, Albert M, Park DC, Lu H. The association between BOLD-based cerebrovascular reactivity (CVR) and end-tidal CO in healthy subjects. Neuroimage. 116365. PMID 31734432 DOI: 10.1016/J.Neuroimage.2019.116365  0.302
2019 Gross AL, Walker KA, Moghekar AR, Pettigrew C, Soldan A, Albert MS, Walston JD. Plasma Markers of Inflammation Linked to Clinical Progression and Decline During Preclinical AD. Frontiers in Aging Neuroscience. 11: 229. PMID 31555121 DOI: 10.3389/Fnagi.2019.00229  0.393
2019 Xiong C, Luo J, Agboola F, Li Y, Albert M, Johnson SC, Koscik RL, Masters CL, Soldan A, Villemagne VL, Li QX, McDade EM, Fagan AM, Massoumzadeh P, Benzinger T, et al. A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31506247 DOI: 10.1016/J.Jalz.2019.06.4955  0.466
2019 Dumitrescu L, Barnes LL, Thambisetty M, Beecham G, Kunkle B, Bush WS, Gifford KA, Chibnik LB, Mukherjee S, De Jager PL, Kukull W, Crane PK, Resnick SM, Keene CD, Montine TJ, ... ... Albert M, et al. Sex differences in the genetic predictors of Alzheimer's pathology. Brain : a Journal of Neurology. 142: 2581-2589. PMID 31497858 DOI: 10.1093/Brain/Awz206  0.378
2019 Coughlin JM, Rubin LH, Du Y, Rowe SP, Crawford JL, Rosenthal HB, Frey SM, Marshall ES, Shinehouse LK, Chen A, Speck CL, Wang Y, Lesniak WG, Minn I, Bakker A, ... ... Albert MS, et al. High availability of the α7 nicotinic acetylcholine receptor in brains of individuals with mild cognitive impairment: A pilot study using F-ASEM PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31420499 DOI: 10.2967/Jnumed.119.230979  0.345
2019 Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, ... ... Albert MS, et al. Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. PMID 31417202 DOI: 10.1038/s41588-019-0495-7  0.451
2019 Liu CF, Padhy S, Ramachandran S, Wang VX, Efimov A, Bernal A, Shi L, Vaillant M, Ratnanather JT, Faria AV, Caffo B, Albert M, Miller MI. Using Deep Siamese Neural Networks for Detection of Brain Asymmetries Associated with Alzheimer's Disease and Mild Cognitive Impairment. Magnetic Resonance Imaging. PMID 31319126 DOI: 10.1016/J.Mri.2019.07.003  0.415
2019 Austad SN, Wood MA, Villeda SA, Voss JL, Sahay A, Albert M. Innovative approaches in cognitive aging. Neurobiology of Aging. PMID 31277894 DOI: 10.1016/J.Neurobiolaging.2019.04.013  0.355
2019 Soldan A, Moghekar A, Walker KA, Pettigrew C, Hou X, Lu H, Miller MI, Alfini A, Albert M, Xu D, Xiao MF, Worley P. Resting-State Functional Connectivity Is Associated With Cerebrospinal Fluid Levels of the Synaptic Protein NPTX2 in Non-demented Older Adults. Frontiers in Aging Neuroscience. 11: 132. PMID 31231205 DOI: 10.3389/Fnagi.2019.00132  0.401
2019 Rawlings AM, Sharrett AR, Albert MS, Coresh J, Windham BG, Power MC, Knopman DS, Walker K, Burgard S, Mosley TH, Gottesman RF, Selvin E. The Association of Late-Life Diabetes Status and Hyperglycemia With Incident Mild Cognitive Impairment and Dementia: The ARIC Study. Diabetes Care. 42: 1248-1254. PMID 31221696 DOI: 10.2337/Dc19-0120  0.358
2019 Lin Z, Sur S, Soldan A, Pettigrew C, Miller M, Oishi K, Bilgel M, Moghekar A, Pillai JJ, Albert M, Lu H. Brain Oxygen Extraction by Using MRI in Older Individuals: Relationship to Apolipoprotein E Genotype and Amyloid Burden. Radiology. 182726. PMID 31012816 DOI: 10.1148/Radiol.2019182726  0.436
2019 Younes L, Albert M, Moghekar A, Soldan A, Pettigrew C, Miller MI. Identifying Changepoints in Biomarkers During the Preclinical Phase of Alzheimer's Disease. Frontiers in Aging Neuroscience. 11: 74. PMID 31001108 DOI: 10.3389/Fnagi.2019.00074  0.446
2019 Wu D, Albert M, Soldan A, Pettigrew C, Oishi K, Tomogane Y, Ye C, Ma T, Miller MI, Mori S. Multi-atlas based detection and localization (MADL) for location-dependent quantification of white matter hyperintensities. Neuroimage. Clinical. 22: 101772. PMID 30927606 DOI: 10.1016/J.Nicl.2019.101772  0.364
2019 Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, ... ... Albert MS, et al. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. 51: 414-430. PMID 30820047 DOI: 10.1038/s41588-019-0358-2  0.462
2019 Sabir MS, Blauwendraat C, Ahmed S, Serrano GE, Beach TG, Perkins M, Rice AC, Masliah E, Morris CM, Pihlstrom L, Pantelyat A, Resnick SM, Cookson MR, Hernandez DG, Albert M, et al. Assessment of APOE in atypical parkinsonism syndromes. Neurobiology of Disease. PMID 30798004 DOI: 10.1016/J.Nbd.2019.02.016  0.378
2019 Hua J, Lee S, Blair NIS, Wyss M, van Bergen JMG, Schreiner SJ, Kagerer SM, Leh SE, Gietl AF, Treyer V, Buck A, Nitsch RM, Pruessmann KP, Lu H, Van Zijl PCM, ... Albert M, et al. Increased cerebral blood volume in small arterial vessels is a correlate of amyloid-β-related cognitive decline. Neurobiology of Aging. 76: 181-193. PMID 30738323 DOI: 10.1016/J.Neurobiolaging.2019.01.001  0.438
2019 Swenor BK, Wang J, Varadaraj V, Rosano C, Yaffe K, Albert M, Simonsick EM. Corrigendum: Vision Impairment and Cognitive Outcomes in Older Adults: The Health ABC Study. Journals of Gerontology Series a-Biological Sciences and Medical Sciences. 74: 1484-1484. PMID 30649211 DOI: 10.1093/Gerona/Gly285  0.325
2019 Koychev I, Vaci N, Bilgel M, Muniz GT, Gallacher J, Resnick S, Albert M. 31 Prediction of emerging amyloid and tau pathology in cognitively healthy individuals: a longitudinal CSF study Journal of Neurology, Neurosurgery, and Psychiatry. 90. DOI: 10.1136/Jnnp-2019-Bnpa.31  0.451
2019 Sur S, Lin Z, Li Y, Yasar S, Rosenberg PB, Moghekar A, Wang Z, Hazel K, Pottanat G, Taneja K, Xu C, Van Zijl P, Pillai J, Liu P, Albert MS, et al. P1-363: CEREBRAL SMALL VESSEL REACTIVITY IS ASSOCIATED WITH COGNITIVE PERFORMANCE INDEPENDENT OF ALZHEIMER PATHOLOGY IN ELDERLY INDIVIDUALS Alzheimer's & Dementia. 15: P391-P392. DOI: 10.1016/J.Jalz.2019.06.918  0.428
2019 Pettigrew C, Soldan A, Wang J, Wang M, Gottesman RF, Moghekar A, Albert MS. O3-09-05: VASCULAR RISK FACTORS AND CSF AD BIOMARKERS ARE INDEPENDENTLY ASSOCIATED WITH COGNITIVE DECLINE Alzheimer's & Dementia. 15: P906-P907. DOI: 10.1016/J.Jalz.2019.06.4676  0.395
2019 Habes M, Pomponio R, Shou H, Doshi J, Sotiras A, Erus G, Launer LJ, Mamourian E, Bilgel M, Yaffe K, Srinivasan D, Espeland MA, Nasrallah IM, Rowe CC, Voelzke H, ... ... Albert MS, et al. IC-P-108: WHITE MATTER HYPERINTENSITIES IN RELATION TO PATTERNS OF ACCELERATED BRAIN AGING, AD-LIKE ATROPHY AND AMYLOID BURDEN: RESULTS FROM THE ISTAGING CONSORTIUM ON MACHINE LEARNING AND LARGE-SCALE IMAGING ANALYTICS Alzheimer's & Dementia. 15: P92-P93. DOI: 10.1016/J.Jalz.2019.06.4222  0.335
2019 Soldan A, Pettigrew C, Zhu Y, Wang M, Gottesman RF, Albert MS. P4-447: COGNITIVE RESERVE MITIGATES THE IMPACT OF HYPERTENSION ON COGNITIVE TRAJECTORIES Alzheimer's & Dementia. 15: P1475-P1475. DOI: 10.1016/J.Jalz.2019.06.4119  0.355
2019 Gross AL, Walker KA, Moghekar A, Pettigrew C, Soldan A, Albert MS, Walston J. P2-550: Plasma Measures Of Inflammation Associated With Clinical Progression And Cognitive Decline During Preclinical Ad Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2958  0.414
2018 Sathe G, Na CH, Renuse S, Madugundu AK, Albert M, Moghekar A, Pandey A. Quantitative proteomic profiling of cerebrospinal fluid to identify candidate biomarkers for Alzheimer's disease. Proteomics. Clinical Applications. e1800105. PMID 30578620 DOI: 10.1002/Prca.201800105  0.391
2018 Kulason S, Tward DJ, Brown T, Sicat CS, Liu CF, Ratnanather JT, Younes L, Bakker A, Gallagher M, Albert M, Miller MI. Cortical thickness atrophy in the transentorhinal cortex in mild cognitive impairment. Neuroimage. Clinical. PMID 30552075 DOI: 10.1016/J.Nicl.2018.101617  0.394
2018 Bell WR, An Y, Kageyama Y, English C, Rudow GL, Pletnikova O, Thambisetty M, O'Brien R, Moghekar AR, Albert MS, Rabins PV, Resnick SM, Troncoso JC. Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy and Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30465754 DOI: 10.1016/J.Jalz.2018.07.215  0.493
2018 Deal JA, Sharrett AR, Albert M, Bandeen-Roche K, Burgard S, Thomas SD, Gottesman RF, Knopman D, Mosley T, Klein B, Klein R. Retinal signs and risk of incident dementia in the Atherosclerosis Risk in Communities study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30439332 DOI: 10.1016/J.Jalz.2018.10.002  0.302
2018 Cabeza R, Albert M, Belleville S, Craik FIM, Duarte A, Grady CL, Lindenberger U, Nyberg L, Park DC, Reuter-Lorenz PA, Rugg MD, Steffener J, Rajah MN. Author Correction: Maintenance, reserve and compensation: the cognitive neuroscience of healthy ageing. Nature Reviews. Neuroscience. PMID 30405175 DOI: 10.1038/S41583-018-0086-0  0.369
2018 Pettigrew C, Shao Y, Zhu Y, Grega M, Brichko R, Wang MC, Carlson MC, Albert M, Soldan A. Self-reported Lifestyle Activities in Relation to Longitudinal Cognitive Trajectories. Alzheimer Disease and Associated Disorders. PMID 30376509 DOI: 10.1097/Wad.0000000000000281  0.367
2018 Deal JA, Goman AM, Albert MS, Arnold ML, Burgard S, Chisolm T, Couper D, Glynn NW, Gmelin T, Hayden KM, Mosley T, Pankow JS, Reed N, Sanchez VA, Richey Sharrett A, et al. Hearing treatment for reducing cognitive decline: Design and methods of the Aging and Cognitive Health Evaluation in Elders randomized controlled trial. Alzheimer's & Dementia (New York, N. Y.). 4: 499-507. PMID 30364572 DOI: 10.1016/J.Trci.2018.08.007  0.379
2018 Swenor BK, Wang J, Varadaraj V, Rosano C, Yaffe K, Albert M, Simonsick EM. Vision Impairment and Cognitive Outcomes in Older Adults: The Health ABC Study. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 30358809 DOI: 10.1093/Gerona/Gly244  0.347
2018 Cabeza R, Albert M, Belleville S, Craik FIM, Duarte A, Grady CL, Lindenberger U, Nyberg L, Park DC, Reuter-Lorenz PA, Rugg MD, Steffener J, Rajah MN. Maintenance, reserve and compensation: the cognitive neuroscience of healthy ageing. Nature Reviews. Neuroscience. PMID 30305711 DOI: 10.1038/S41583-018-0068-2  0.393
2018 Pletnikova O, Kageyama Y, Rudow G, LaClair KD, Albert M, Crain BJ, Tian J, Fowler D, Troncoso JC. The spectrum of preclinical Alzheimer's disease pathology and its modulation by ApoE genotype. Neurobiology of Aging. 71: 72-80. PMID 30099348 DOI: 10.1016/J.Neurobiolaging.2018.07.007  0.384
2018 Hohman TJ, Dumitrescu L, Barnes LL, Thambisetty M, Beecham G, Kunkle B, Gifford KA, Bush WS, Chibnik LB, Mukherjee S, De Jager PL, Kukull W, Crane PK, Resnick SM, Keene CD, ... ... Albert M, et al. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. Jama Neurology. PMID 29801024 DOI: 10.1001/Jamaneurol.2018.0821  0.369
2018 Wolk DA, Sadowsky C, Safirstein B, Rinne JO, Duara R, Perry R, Agronin M, Gamez J, Shi J, Ivanoiu A, Minthon L, Walker Z, Hasselbalch S, Holmes C, Sabbagh M, ... Albert M, et al. Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment. Jama Neurology. PMID 29799984 DOI: 10.1001/Jamaneurol.2018.0894  0.442
2018 Knopman DS, Gottesman RF, Sharrett AR, Tapia AL, DavisThomas S, Windham BG, Coker L, Schneider ALC, Alonso A, Coresh J, Albert MS, Mosley TH. Midlife vascular risk factors and midlife cognitive status in relation to prevalence of mild cognitive impairment and dementia in later life: The Atherosclerosis Risk in Communities Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29763593 DOI: 10.1016/J.Jalz.2018.03.011  0.396
2018 Deal JA, Sharrett AR, Rawlings AM, Gottesman RF, Bandeen-Roche K, Albert M, Knopman D, Selvin E, Wasserman BA, Klein B, Klein R. Retinal signs and 20-year cognitive decline in the Atherosclerosis Risk in Communities Study. Neurology. PMID 29490915 DOI: 10.1212/Wnl.0000000000005205  0.342
2018 Cholerton B, Johnson CO, Fish B, Quinn JF, Chung KA, Peterson-Hiller AL, Rosenthal LS, Dawson TM, Albert MS, Hu SC, Mata IF, Leverenz JB, Poston KL, Montine TJ, Zabetian CP, et al. Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease. Parkinsonism & Related Disorders. PMID 29478836 DOI: 10.1016/J.Parkreldis.2018.02.007  0.419
2018 Soldan A, Pettigrew C, Albert M. Evaluating Cognitive Reserve Through the Prism of Preclinical Alzheimer Disease. The Psychiatric Clinics of North America. 41: 65-77. PMID 29412849 DOI: 10.1016/J.Psc.2017.10.006  0.452
2018 Klinger RY, James OG, Borges-Neto S, Bisanar T, Li YJ, Qi W, Berger M, Terrando N, Newman MF, Doraiswamy PM, Mathew JP, Weiner MW, Aisen P, Weiner M, Aisen P, ... ... Albert M, ... ... Albert M, et al. 18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery. Anesthesiology. PMID 29389750 DOI: 10.1097/Aln.0000000000002103  0.682
2018 Albert M, Zhu Y, Moghekar A, Mori S, Miller MI, Soldan A, Pettigrew C, Selnes O, Li S, Wang MC. Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years. Brain : a Journal of Neurology. PMID 29365053 DOI: 10.1093/Brain/Awx365  0.347
2018 Kulason S, Tward DJ, Sicat CS, Bakker A, Gallagher M, Albert MS, Miller M. Ic-P-098: Cortical Thickness Atrophy In The Transentorhinal Cortex In Mild Cognitive Impairment Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2162  0.358
2018 Dumitrescu L, Deming Y, Lu Q, Beecham GW, Kunkle BW, Del-Aguila JL, Fernandez MV, Budde JP, Fagan AM, Jager PLD, Albert MS, Moghekar A, Riemenschneider M, Petersen RC, Barnes LL, et al. P1-139: The Contribution Of Sex-Specific Associations In Genetic Studies Of Alzheimer'S Disease Pathology Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.142  0.372
2018 Chan CK, Soldan A, Pettigrew C, Wang MC, Wang J, Albert M, Rosenberg PB. Depression Severity in Relation to Clinical Symptom Onset in Mild Cognitive Impairment The American Journal of Geriatric Psychiatry. 26: S140-S141. DOI: 10.1016/J.Jagp.2018.01.171  0.335
2017 Deal JA, Albert MS, Arnold M, Bangdiwala SI, Chisolm T, Davis S, Eddins A, Glynn NW, Goman AM, Minotti M, Mosley T, Rebok GW, Reed N, Rodgers E, Sanchez V, et al. A randomized feasibility pilot trial of hearing treatment for reducing cognitive decline: Results from the Aging and Cognitive Health Evaluation in Elders Pilot Study. Alzheimer's & Dementia (New York, N. Y.). 3: 410-415. PMID 29067347 DOI: 10.1016/J.Trci.2017.06.003  0.388
2017 Graff-Radford J, Simino J, Kantarci K, Mosley TH, Griswold ME, Windham BG, Sharrett AR, Albert MS, Gottesman RF, Jack CR, Vemuri P, Knopman DS. Neuroimaging Correlates of Cerebral Microbleeds: The ARIC Study (Atherosclerosis Risk in Communities). Stroke. PMID 29018129 DOI: 10.1161/Strokeaha.117.018336  0.346
2017 Tward DJ, Sicat CS, Brown T, Bakker A, Gallagher M, Albert M, Miller M. Entorhinal and transentorhinal atrophy in mild cognitive impairment using longitudinal diffeomorphometry. Alzheimer's & Dementia (Amsterdam, Netherlands). 9: 41-50. PMID 28971142 DOI: 10.1016/J.Dadm.2017.07.005  0.435
2017 Soldan A, Pettigrew C, Cai Q, Wang J, Wang MC, Moghekar A, Miller MI, Albert M. Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease. Neurobiology of Aging. 60: 164-172. PMID 28968586 DOI: 10.1016/J.Neurobiolaging.2017.09.002  0.459
2017 Gottesman RF, Albert MS, Alonso A, Coker LH, Coresh J, Davis SM, Deal JA, McKhann GM, Mosley TH, Sharrett AR, Schneider ALC, Windham BG, Wruck LM, Knopman DS. Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort. Jama Neurology. PMID 28783817 DOI: 10.1001/Jamaneurol.2017.1658  0.341
2017 Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, ... ... Albert MS, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics. PMID 28714976 DOI: 10.1038/Ng.3916  0.517
2017 Gross AL, Hassenstab JJ, Johnson SC, Clark LR, Resnick SM, Kitner-Triolo M, Masters CL, Maruff P, Morris JC, Soldan A, Pettigrew C, Albert MS. A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 147-155. PMID 28653035 DOI: 10.1016/J.Dadm.2017.05.003  0.458
2017 Tzuang M, Owusu JT, Spira AP, Albert MS, Rebok GW. Cognitive Training for Ethnic Minority Older Adults in the United States: A Review. The Gerontologist. PMID 28575230 DOI: 10.1093/Geront/Gnw260  0.333
2017 Wennberg AMV, Hagen CE, Gottesman RF, Zipunnikov V, Kaufmann CN, Albert MS, Rebok GW, Kasper JD, Spira AP. Longitudinal association between diabetes and cognitive decline: The National Health and Aging Trends Study. Archives of Gerontology and Geriatrics. 72: 39-44. PMID 28544945 DOI: 10.1016/J.Archger.2017.05.005  0.377
2017 Sacktor N, Soldan A, Grega M, Farrington L, Cai Q, Wang MC, Gottesman RF, Turner RS, Albert M. The BIOCARD Index: A Summary Measure to Predict Onset of Mild Cognitive Impairment. Alzheimer Disease and Associated Disorders. PMID 28394770 DOI: 10.1097/Wad.0000000000000194  0.406
2017 Thaker AA, Weinberg BD, Dillon WP, Hess CP, Cabral HJ, Fleischman DA, Leurgans SE, Bennett DA, Hyman BT, Albert MS, Killiany RJ, Fischl B, Dale AM, Desikan RS. Entorhinal Cortex: Antemortem Cortical Thickness and Postmortem Neurofibrillary Tangles and Amyloid Pathology. Ajnr. American Journal of Neuroradiology. PMID 28279988 DOI: 10.3174/Ajnr.A5133  0.316
2017 Couser E, Albert M, Pettigrew C, Soldan A. COGNITIVE MEASURE MAY IDENTIFY ATROPHY IN BRAIN REGIONS ASSOCIATED WITH POSTERIOR CORTICAL ATROPHY Innovation in Aging. 1: 587-587. DOI: 10.1093/Geroni/Igx004.2060  0.373
2017 Deming Y, Kapoor M, Li Z, Harari O, Black K, Del-Aguila JL, Carrell D, Cai Y, Fernandez MV, Budde JP, Ma S, Saef B, Howells B, Huang K, Bertelsen S, ... ... Albert MS, et al. CEREBROSPINAL FLUID ENDOPHENOTYPES PROVIDE INSIGHT INTO BIOLOGY UNDERLYING ALZHEIMER'S DISEASE Alzheimer's & Dementia. 13: P218-P219. DOI: 10.1016/J.Jalz.2017.07.096  0.358
2016 McAdams-DeMarco MA, Bae S, Chu N, Gross AL, Brown CH, Oh E, Rosenberg P, Neufeld KJ, Varadhan R, Albert M, Walston J, Segev DL. Dementia and Alzheimer's Disease among Older Kidney Transplant Recipients. Journal of the American Society of Nephrology : Jasn. PMID 27979990 DOI: 10.1681/ASN.2016080816  0.389
2016 Chapuis J, Flaig A, Grenier-Boley B, Eysert F, Pottiez V, Deloison G, Vandeputte A, Ayral AM, Mendes T, Desai S, Goate AM, Kauwe JS, Leroux F, Herledan A, Demiautte F, ... ... Albert M, et al. Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism. Acta Neuropathologica. PMID 27933404 DOI: 10.1007/S00401-016-1652-Z  0.342
2016 Soldan A, Pettigrew C, Moghekar A, Albert M. Computerized Cognitive Tests Are Associated with Biomarkers of Alzheimer's Disease in Cognitively Normal Individuals 10 Years Prior. Journal of the International Neuropsychological Society : Jins. 22: 968-977. PMID 27903332 DOI: 10.1017/S1355617716000722  0.48
2016 Gross AL, Mungas DM, Leoutsakos JS, Albert MS, Jones RN. Alzheimer's disease severity, objectively determined and measured. Alzheimer's & Dementia (Amsterdam, Netherlands). 4: 159-168. PMID 27830173 DOI: 10.1016/J.Dadm.2016.08.005  0.418
2016 Davis MY, Johnson CO, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Quinn JF, Chung KA, Peterson-Hiller AL, Rosenthal LS, Dawson TM, Albert MS, Goldman JG, Stebbins GT, et al. Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease. Jama Neurology. PMID 27571329 DOI: 10.1001/Jamaneurol.2016.2245  0.323
2016 Pettigrew C, Soldan A, Zhu Y, Wang MC, Brown T, Miller M, Albert M. Cognitive reserve and cortical thickness in preclinical Alzheimer's disease. Brain Imaging and Behavior. PMID 27544202 DOI: 10.1007/S11682-016-9581-Y  0.44
2016 Pettigrew C, Soldan A, Zhu Y, Wang MC, Moghekar A, Brown T, Miller M, Albert M. Cortical thickness in relation to clinical symptom onset in preclinical AD. Neuroimage. Clinical. 12: 116-22. PMID 27408796 DOI: 10.1016/J.Nicl.2016.06.010  0.368
2016 Geiger JT, Ding J, Crain B, Pletnikova O, Letson C, Dawson TM, Rosenthal LS, Pantelyat A, Gibbs JR, Albert MS, Hernandez DG, Hillis AE, Stone DJ, Singleton AB, et al. Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies. Neurobiology of Disease. PMID 27312774 DOI: 10.1016/J.Nbd.2016.06.004  0.313
2016 Geiger JT, Arthur KC, Dawson TM, Rosenthal LS, Pantelyat A, Albert M, Hillis AE, Crain B, Pletnikova O, Troncoso JC, Scholz SW. C9orf72 Hexanucleotide Repeat Analysis in Cases with Pathologically Confirmed Dementia with Lewy Bodies. Neuro-Degenerative Diseases. 16: 370-372. PMID 27241037 DOI: 10.1159/000445872  0.35
2016 Wennberg AM, Spira AP, Pettigrew C, Soldan A, Zipunnikov V, Rebok GW, Roses AD, Lutz MW, Miller MM, Thambisetty M, Albert MS. Blood glucose levels and cortical thinning in cognitively normal, middle-aged adults. Journal of the Neurological Sciences. 365: 89-95. PMID 27206882 DOI: 10.1016/J.Jns.2016.04.017  0.396
2016 Soldan A, Pettigrew C, Cai Q, Wang MC, Moghekar AR, O'Brien RJ, Selnes OA, Albert MS. Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change. Jama Neurology. PMID 27064267 DOI: 10.1001/Jamaneurol.2016.0194  0.445
2016 Knopman DS, Gottesman RF, Sharrett AR, Wruck LM, Windham BG, Coker L, Schneider AL, Hengrui S, Alonso A, Coresh J, Albert MS, Mosley TH. Mild Cognitive Impairment and Dementia Prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). Alzheimer's & Dementia (Amsterdam, Netherlands). 2: 1-11. PMID 26949733 DOI: 10.1016/J.Dadm.2015.12.002  0.399
2016 Thomas RG, Albert M, Petersen RC, Aisen PS. Longitudinal decline in mild-to-moderate Alzheimer's disease: Analyses of placebo data from clinical trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26917500 DOI: 10.1016/J.Jalz.2016.01.002  0.465
2016 McCutcheon ST, Han D, Troncoso J, Koliatsos VE, Albert M, Lyketsos CG, Leoutsakos JS. Clinicopathological correlates of depression in early Alzheimer's disease in the NACC. International Journal of Geriatric Psychiatry. PMID 26876501 DOI: 10.1002/Gps.4435  0.424
2016 Deming Y, Harari O, Black K, Carrell D, Cai Y, Del-Aguila JL, Fernandez V, Budde J, Ma S, Saef B, Bertelsen S, Kauwe J, Fagan AM, Holtzman DM, Morris JC, ... ... Albert MS, et al. Cerebrospinal Fluid Levels Of Amyloid Beta And Tau As Endophenotypes Reveal Novel Variants Potentially Informative For Alzheimer'S Disease Alzheimers & Dementia. 12: 252. DOI: 10.1016/J.Jalz.2016.06.452  0.336
2016 Lin FR, Albert MS, Alonso A, Bangdiwala S, Chisolm T, Coker L, Deal J, Davis S, Minotti M, Mosley TH, Rebok G, Sharrett R, Coresh J. P3-033: Results from the Achieve-P Study: A Pilot Study for a Randomized Controlled Trial to Determine if Hearing Loss Treatment Can Reduce the Risk of Cognitive Decline in Older Adults Alzheimer's & Dementia. 12: P829-P830. DOI: 10.1016/J.Jalz.2016.06.1690  0.328
2016 Varma VR, Varma S, An Y, Beri A, Dammer EB, Seyfried NT, Moghekar A, Wilson M, Lah JJ, O’Brien R, Levey AI, Troncoso JC, Albert MS, Thambisetty M. The Acute Phase Protein Alpha-2-Macroglobulin Predicts Risk Of Incident Alzheimer'S Disease And Modulates Tau Pathology Through The Rcan1-Calcineurin Pathway Alzheimers & Dementia. 12: 745. DOI: 10.1016/J.Jalz.2016.06.1554  0.317
2015 Gauthier S, Albert M, Fox N, Goedert M, Kivipelto M, Mestre-Ferrandiz J, Middleton LT. "Why therapy development for dementia has failed in the last two decades?" Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26710325 DOI: 10.1016/J.Jalz.2015.12.003  0.3
2015 Gross AL, Power MC, Albert MS, Deal JA, Gottesman RF, Griswold M, Wruck LM, Mosley TH, Coresh J, Sharrett AR, Bandeen-Roche K. Application of Latent Variable Methods to the Study of Cognitive Decline When Tests Change over Time. Epidemiology (Cambridge, Mass.). 26: 878-87. PMID 26414855 DOI: 10.1097/Ede.0000000000000379  0.384
2015 Pettigrew C, Soldan A, Moghekar A, Wang MC, Gross AL, O'Brien R, Albert M. Relationship between Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Cognition in Cognitively Normal Older Adults. Neuropsychologia. PMID 26394023 DOI: 10.1016/J.Neuropsychologia.2015.09.024  0.37
2015 Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Ritz B, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson-Hiller AL, Goldman JG, Stebbins GT, ... ... Albert MS, et al. GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26296077 DOI: 10.1002/Mds.26359  0.354
2015 Miller MI, Ratnanather JT, Tward DJ, Brown T, Lee DS, Ketcha M, Mori K, Wang MC, Mori S, Albert MS, Younes L. Network Neurodegeneration in Alzheimer's Disease via MRI Based Shape Diffeomorphometry and High-Field Atlasing. Frontiers in Bioengineering and Biotechnology. 3: 54. PMID 26284236 DOI: 10.3389/Fbioe.2015.00054  0.37
2015 Toledo JB, Zetterberg H, van Harten AC, Glodzik L, Martinez-Lage P, Bocchio-Chiavetto L, Rami L, Hansson O, Sperling R, Engelborghs S, Osorio RS, Vanderstichele H, Vandijck M, Hampel H, Teipl S, ... ... Albert M, et al. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. Brain : a Journal of Neurology. 138: 2701-15. PMID 26220940 DOI: 10.1093/Brain/Awv199  0.511
2015 Resnick SM, Bilgel M, Moghekar A, An Y, Cai Q, Wang MC, Thambisetty M, Prince JL, Zhou Y, Soldan A, Wong DF, O'Brien RJ, Ferrucci L, Albert MS. Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts. Neurobiology of Aging. 36: 2333-9. PMID 26004017 DOI: 10.1016/J.Neurobiolaging.2015.04.001  0.453
2015 Deal JA, Sharrett AR, Albert MS, Coresh J, Mosley TH, Knopman D, Wruck LM, Lin FR. Hearing impairment and cognitive decline: a pilot study conducted within the atherosclerosis risk in communities neurocognitive study. American Journal of Epidemiology. 181: 680-90. PMID 25841870 DOI: 10.1093/Aje/Kwu333  0.397
2015 Carlson MC, Kuo JH, Chuang YF, Varma VR, Harris G, Albert MS, Erickson KI, Kramer AF, Parisi JM, Xue QL, Tan EJ, Tanner EK, Gross AL, Seeman TE, Gruenewald TL, et al. Impact of the Baltimore Experience Corps Trial on cortical and hippocampal volumes. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25835516 DOI: 10.1016/J.Jalz.2014.12.005  0.561
2015 Srivatsal S, Cholerton B, Leverenz JB, Wszolek ZK, Uitti RJ, Dickson DW, Weintraub D, Trojanowski JQ, Van Deerlin VM, Quinn JF, Chung KA, Peterson AL, Factor SA, Wood-Siverio C, Goldman JG, ... ... Albert MS, et al. Cognitive profile of LRRK2-related Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 728-33. PMID 25650144 DOI: 10.1002/Mds.26161  0.327
2015 Knopman DS, Griswold ME, Lirette ST, Gottesman RF, Kantarci K, Sharrett AR, Jack CR, Graff-Radford J, Schneider AL, Windham BG, Coker LH, Albert MS, Mosley TH. Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study. Stroke; a Journal of Cerebral Circulation. 46: 433-40. PMID 25563642 DOI: 10.1161/Strokeaha.114.007847  0.353
2015 Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, ... ... Albert MS, et al. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. Jama Neurology. 72: 209-16. PMID 25531812 DOI: 10.1001/Jamaneurol.2014.2157  0.415
2015 Miller MI, Younes L, Ratnanather JT, Brown T, Trinh H, Lee DS, Tward D, Mahon PB, Mori S, Albert M. Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: the BIOCARD cohort. Neurobiology of Aging. 36: S3-S10. PMID 25444602 DOI: 10.1016/J.Neurobiolaging.2014.06.032  0.429
2015 Nowrangi MA, Okonkwo O, Lyketsos C, Oishi K, Mori S, Albert M, Mielke MM. Atlas-based diffusion tensor imaging correlates of executive function. Journal of Alzheimer's Disease : Jad. 44: 585-98. PMID 25318544 DOI: 10.3233/Jad-141937  0.416
2015 Toledo JB, Zetterberg H, Van Harten AC, Glodzik L, Martinez-Lage P, Bocchio-Chiavetto L, Rami L, Hansson O, Sperling R, Engelborghs S, Osorio RS, Vanderstichele H, Vandijck M, Hampel H, Teipl S, ... ... Albert M, et al. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects Brain. 138: 2701-2715. DOI: 10.1093/brain/awv199  0.441
2015 Albert MS, Soldan A, Selnes O, Miller M, Ratnanather T, Mori S, Moghekar A, O'Brien R, Scherer R, Li S, Wang M. F1-03-02: Using combinations of variables to identify individuals with preclinical ad Alzheimer's & Dementia. 11: P118-P118. DOI: 10.1016/J.Jalz.2015.07.015  0.301
2015 Breitner JCS, Albert MS, Poirier J, Etienne PE. Potential of ad biomarkers to reveal the presymptomatic disease process and the effects of treatments that may retard it Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.014  0.358
2015 Lutz MW, Soldan A, Selnes O, Roses AD, Saunders AM, Burns DK, Albert MS. P3-018: Tomm40/ApoE variation and age of onset of mild cognitive impairment and dementia in a prospective, longitudinal study Alzheimer's & Dementia. 11: P626-P627. DOI: 10.1016/J.Jalz.2015.06.884  0.445
2015 Soldan A, Pettigrew CA, Cai Q, Wang M, Moghekar A, Miller M, Ratnanather T, Mori S, Albert MS. P1-113: Relationship of CSF tau and ß-amyloid to hippocampal atrophy rates Alzheimer's & Dementia. 11: P383-P383. DOI: 10.1016/J.Jalz.2015.06.311  0.312
2015 Gross AL, Mungas D, Albert MS, Leoutsakos JS, Jones RN. Alzheimer disease severity objectively determined and measured Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.1849  0.345
2015 Lin F, Albert MS, Alonso A, Chisolm T, Coker L, Crowley P, Deal J, Eddins A, Minotti M, Mosley T, Rebok G, Sharrett R, Wruck L, Coresh J. P3-312: Development of the achieve healthy aging study: A randomized controlled trial to determine if hearing loss treatment can reduce the risk of cognitive decline and dementia in older adults Alzheimer's & Dementia. 11: P756-P757. DOI: 10.1016/J.Jalz.2015.06.1686  0.378
2015 Wennberg AM, Zipunnikov V, Kaufmann CN, Gottesman RF, Albert M, Rebok GW, Kasper JD, Spira AP. Longitudinal Association Between Diabetes and Cognitive Decline in a Nationally Representative Sample: The National Health and Aging Trends Study The American Journal of Geriatric Psychiatry. 23: S93-S94. DOI: 10.1016/J.Jagp.2014.12.095  0.344
2014 Rawlings AM, Sharrett AR, Schneider AL, Coresh J, Albert M, Couper D, Griswold M, Gottesman RF, Wagenknecht LE, Windham BG, Selvin E. Diabetes in midlife and cognitive change over 20 years: a cohort study. Annals of Internal Medicine. 161: 785-93. PMID 25437406 DOI: 10.7326/M14-0737  0.317
2014 Fargo KN, Aisen P, Albert M, Au R, Corrada MM, DeKosky S, Drachman D, Fillit H, Gitlin L, Haas M, Herrup K, Kawas C, Khachaturian AS, Khachaturian ZS, et al. 2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: S430-52. PMID 25341459 DOI: 10.1016/J.Jalz.2014.08.103  0.613
2014 Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, ... ... Albert MS, et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. Jama Neurology. 71: 1394-404. PMID 25199842 DOI: 10.1001/Jamaneurol.2014.1491  0.525
2014 Hughes TB, Black BS, Albert M, Gitlin LN, Johnson DM, Lyketsos CG, Samus QM. Correlates of objective and subjective measures of caregiver burden among dementia caregivers: influence of unmet patient and caregiver dementia-related care needs. International Psychogeriatrics / Ipa. 26: 1875-83. PMID 25104063 DOI: 10.1017/S1041610214001240  0.305
2014 Younes L, Albert M, Miller MI. Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease. Neuroimage. Clinical. 5: 178-87. PMID 25101236 DOI: 10.1016/J.Nicl.2014.04.009  0.308
2014 Gottesman RF, Schneider AL, Albert M, Alonso A, Bandeen-Roche K, Coker L, Coresh J, Knopman D, Power MC, Rawlings A, Sharrett AR, Wruck LM, Mosley TH. Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study. Jama Neurology. 71: 1218-27. PMID 25090106 DOI: 10.1001/Jamaneurol.2014.1646  0.39
2014 Wennberg AM, Gottesman RF, Kaufmann CN, Albert MS, Chen-Edinboro LP, Rebok GW, Kasper JD, Spira AP. Diabetes and cognitive outcomes in a nationally representative sample: the National Health and Aging Trends Study. International Psychogeriatrics / Ipa. 26: 1729-35. PMID 25075535 DOI: 10.1017/S1041610214001380  0.36
2014 Lin FR, Albert M. Hearing loss and dementia - who is listening? Aging & Mental Health. 18: 671-3. PMID 24875093 DOI: 10.1080/13607863.2014.915924  0.387
2014 Cosentino S, Zahodne LB, Brandt J, Blacker D, Albert M, Dubois B, Stern Y. Social cognition in Alzheimer's disease: a separate construct contributing to dependence. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 818-26. PMID 24656839 DOI: 10.1016/J.Jalz.2013.12.021  0.431
2014 Gottesman RF, Rawlings AM, Sharrett AR, Albert M, Alonso A, Bandeen-Roche K, Coker LH, Coresh J, Couper DJ, Griswold ME, Heiss G, Knopman DS, Patel MD, Penman AD, Power MC, et al. Impact of differential attrition on the association of education with cognitive change over 20 years of follow-up: the ARIC neurocognitive study. American Journal of Epidemiology. 179: 956-66. PMID 24627572 DOI: 10.1093/Aje/Kwu020  0.384
2014 Gu Y, Scarmeas N, Cosentino S, Brandt J, Albert M, Blacker D, Dubois B, Stern Y. Change in body mass index before and after Alzheimer's disease onset. Current Alzheimer Research. 11: 349-56. PMID 24251397 DOI: 10.2174/1567205010666131120110930  0.37
2014 Razlighi QR, Stallard E, Brandt J, Blacker D, Albert M, Scarmeas N, Kinosian B, Yashin AI, Stern Y. A new algorithm for predicting time to disease endpoints in Alzheimer's disease patients. Journal of Alzheimer's Disease : Jad. 38: 661-8. PMID 24064468 DOI: 10.3233/Jad-131142  0.339
2014 Zhang Y, Zhang J, Hsu J, Oishi K, Faria AV, Albert M, Miller MI, Mori S. Evaluation of group-specific, whole-brain atlas generation using Volume-based Template Estimation (VTE): application to normal and Alzheimer's populations. Neuroimage. 84: 406-19. PMID 24051356 DOI: 10.1016/J.Neuroimage.2013.09.011  0.301
2013 Li S, Okonkwo O, Albert M, Wang MC. Variation in Variables that Predict Progression from MCI to AD Dementia over Duration of Follow-up. American Journal of Alzheimer's Disease (Columbia, Mo.). 2: 12-28. PMID 24524014 DOI: 10.7726/ajad.2013.1002  0.391
2013 Miller MI, Younes L, Ratnanather JT, Brown T, Trinh H, Postell E, Lee DS, Wang MC, Mori S, O'Brien R, Albert M. The diffeomorphometry of temporal lobe structures in preclinical Alzheimer's disease. Neuroimage. Clinical. 3: 352-60. PMID 24363990 DOI: 10.1016/J.Nicl.2013.09.001  0.38
2013 Moghekar A, Li S, Lu Y, Li M, Wang MC, Albert M, O'Brien R. CSF biomarker changes precede symptom onset of mild cognitive impairment. Neurology. 81: 1753-8. PMID 24132375 DOI: 10.1212/01.Wnl.0000435558.98447.17  0.431
2013 Soldan A, Pettigrew C, Li S, Wang MC, Moghekar A, Selnes OA, Albert M, O'Brien R. Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease. Neurobiology of Aging. 34: 2827-34. PMID 23916061 DOI: 10.1016/J.Neurobiolaging.2013.06.017  0.424
2013 Zhu CW, Livote EE, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 733-40. PMID 23332671 DOI: 10.1016/J.Jalz.2012.09.015  0.421
2013 Nowrangi MA, Lyketsos CG, Leoutsakos JM, Oishi K, Albert M, Mori S, Mielke MM. Longitudinal, region-specific course of diffusion tensor imaging measures in mild cognitive impairment and Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 519-28. PMID 23245561 DOI: 10.1016/J.Jalz.2012.05.2186  0.446
2013 Chuang Y, Varma V, Haris G, Albert M, Fried L, Rebok G, Xue Q, Carlson M. The association between cardiovascular risk and neurocognitive measures of executive function in at-risk, community-dwelling older adults: An fMRI study Alzheimers & Dementia. 9: 397. DOI: 10.1016/J.Jalz.2013.05.785  0.534
2013 Langbaum J, High N, Aisen P, Albert M, Brown K, Comer M, Cummings J, Manly J, Petersen R, Sperling R, Strobel G, Weiner M, Tariot P, Reiman E. Development and implementation of the National Alzheimer's Prevention Registry Alzheimers & Dementia. 9: 280. DOI: 10.1016/J.Jalz.2013.05.560  0.485
2013 Gu Y, Scarmeas N, Cosentino SA, Brandt J, Albert M, Blacker D, Dubois B, Mayeux R, Stern Y. P1-157: Body mass change in Alzheimer's disease Alzheimer's & Dementia. 9: P206-P207. DOI: 10.1016/J.Jalz.2013.05.380  0.335
2013 Miller MI, Younes L, Ratnanather J, Brown T, Wang M, Lu Y, Li S, Pettigrew C, Mori S, Albert M. Medial temporal lobe changes preceding symptom onset of mild cognitive impairment: The BIOCARD Cohort Alzheimers & Dementia. 9: 54. DOI: 10.1016/J.Jalz.2013.05.091  0.374
2013 Soldan A, Pettigrew C, Wang M, Li S, Lu Y, Albert M, Selnes O. O1-04-06: Relationship of cognitive reserve and APOE status to clinical symptom onset of mild cognitive impairment: The BIOCARD Cohort Alzheimer's & Dementia. 9: P134-P134. DOI: 10.1016/J.Jalz.2013.04.072  0.378
2012 Miller MI, Younes L, Ratnanather JT, Brown T, Reigel T, Trinh H, Tang X, Barker P, Mori S, Albert M. Amygdala Atrophy in MCI/Alzheimer's Disease in the BIOCARD cohort based on Diffeomorphic Morphometry. Medical Image Computing and Computer-Assisted Intervention : Miccai ... International Conference On Medical Image Computing and Computer-Assisted Intervention. 2012: 155-166. PMID 24955432  0.312
2012 Tighe SK, Oishi K, Mori S, Smith GS, Albert M, Lyketsos CG, Mielke MM. Diffusion tensor imaging of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's dementia. The Journal of Neuropsychiatry and Clinical Neurosciences. 24: 484-8. PMID 23224456 DOI: 10.1176/Appi.Neuropsych.11120375  0.445
2012 Mielke MM, Bandaru VV, Haughey NJ, Xia J, Fried LP, Yasar S, Albert M, Varma V, Harris G, Schneider EB, Rabins PV, Bandeen-Roche K, Lyketsos CG, Carlson MC. Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II. Neurology. 79: 633-41. PMID 22815558 DOI: 10.1212/Wnl.0B013E318264E380  0.413
2012 Bakker A, Krauss GL, Albert MS, Speck CL, Jones LR, Stark CE, Yassa MA, Bassett SS, Shelton AL, Gallagher M. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron. 74: 467-74. PMID 22578498 DOI: 10.1016/J.Neuron.2012.03.023  0.406
2012 Mielke MM, Okonkwo OC, Oishi K, Mori S, Tighe S, Miller MI, Ceritoglu C, Brown T, Albert M, Lyketsos CG. Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 105-13. PMID 22404852 DOI: 10.1016/J.Jalz.2011.05.2416  0.426
2012 Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, ... ... Albert M, et al. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proceedings of the National Academy of Sciences of the United States of America. 109: 3985-90. PMID 22343285 DOI: 10.1073/Pnas.1105829109  0.688
2012 Moghekar A, Goh J, Li M, Albert M, O'Brien RJ. Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort. Archives of Neurology. 69: 246-50. PMID 22332192 DOI: 10.1001/Archneurol.2011.732  0.373
2012 Okereke OI, Pantoja-Galicia N, Copeland M, Hyman BT, Wanggaard T, Albert MS, Betensky RA, Blacker D. The SIST-M: predictive validity of a brief structured clinical dementia rating interview. Alzheimer Disease and Associated Disorders. 26: 225-31. PMID 21986342 DOI: 10.1097/Wad.0B013E318231Cd30  0.38
2012 Oishi K, Mielke MM, Albert M, Lyketsos CG, Mori S. The fornix sign: a potential sign for Alzheimer's disease based on diffusion tensor imaging. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 22: 365-74. PMID 21848679 DOI: 10.1111/J.1552-6569.2011.00633.X  0.425
2012 Oishi K, Mielke M, Albert M, Lyketsos C, Mori S. Neuroanatomical Correlates of Cognitive and Neuropsychiatric Worsening in Alzheimer's Disease: Whole-Brain Longitudinal DTI Analysis (P03.092) Neurology. 78: P03.092-P03.092. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P03.092  0.443
2012 Mckhann GM, Albert MS, Sperling RA. Changing diagnostic concepts of Alzheimer's disease Advances in Biological Psychiatry. 28: 115-121. DOI: 10.1159/000335402  0.436
2012 Aisen P, Thomas R, Carrillo M, Mohs R, Petersen R, Siuciak J, Albert M. The Placebo Data Analysis in Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) Clinical Trials Project: Overview of progress in trial data collection, and key findings from the pooled Alzheimer's disease trial datasets Alzheimers & Dementia. 8: 590. DOI: 10.1016/J.Jalz.2012.05.1609  0.356
2011 Silverberg NB, Ryan LM, Carrillo MC, Sperling R, Petersen RC, Posner HB, Snyder PJ, Hilsabeck R, Gallagher M, Raber J, Rizzo A, Possin K, King J, Kaye J, Ott BR, ... Albert MS, et al. Assessment of cognition in early dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: e60-e76. PMID 23559893 DOI: 10.1016/J.Jalz.2011.05.001  0.582
2011 Reiman EM, McKhann GM, Albert MS, Sperling RA, Petersen RC, Blacker D. Clinical impact of updated diagnostic and research criteria for Alzheimer's disease. The Journal of Clinical Psychiatry. 72: e37. PMID 22244033 DOI: 10.4088/Jcp.10087Tx2C  0.555
2011 Albert MS. Changes in cognition. Neurobiology of Aging. 32: S58-63. PMID 22078174 DOI: 10.1016/J.Neurobiolaging.2011.09.010  0.465
2011 Oishi K, Mielke MM, Albert M, Lyketsos CG, Mori S. DTI analyses and clinical applications in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 26: 287-96. PMID 21971468 DOI: 10.3233/Jad-2011-0007  0.428
2011 Reiman EM, McKhann GM, Albert MS, Sperling RA, Petersen RC, Blacker D. Alzheimer's disease: implications of the updated diagnostic and research criteria. The Journal of Clinical Psychiatry. 72: 1190-6. PMID 21951985 DOI: 10.4088/Jcp.10087Co1C  0.502
2011 Oishi K, Akhter K, Mielke M, Ceritoglu C, Zhang J, Jiang H, Li X, Younes L, Miller MI, van Zijl PC, Albert M, Lyketsos CG, Mori S. Multi-modal MRI analysis with disease-specific spatial filtering: initial testing to predict mild cognitive impairment patients who convert to Alzheimer's disease. Frontiers in Neurology. 2: 54. PMID 21904533 DOI: 10.3389/Fneur.2011.00054  0.455
2011 Snyder PJ, Jackson CE, Petersen RC, Khachaturian AS, Kaye J, Albert MS, Weintraub S. Assessment of cognition in mild cognitive impairment: a comparative study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 338-55. PMID 21575877 DOI: 10.1016/J.Jalz.2011.03.009  0.421
2011 Smith EE, Salat DH, Jeng J, McCreary CR, Fischl B, Schmahmann JD, Dickerson BC, Viswanathan A, Albert MS, Blacker D, Greenberg SM. Correlations between MRI white matter lesion location and executive function and episodic memory. Neurology. 76: 1492-9. PMID 21518999 DOI: 10.1212/Wnl.0B013E318217E7C8  0.597
2011 Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 270-9. PMID 21514249 DOI: 10.1016/j.jalz.2011.03.008  0.368
2011 Jack CR, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B, Phelps CH. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 257-62. PMID 21514247 DOI: 10.1016/J.Jalz.2011.03.004  0.556
2011 Dickerson BC, Stoub TR, Shah RC, Sperling RA, Killiany RJ, Albert MS, Hyman BT, Blacker D, Detoledo-Morrell L. Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology. 76: 1395-402. PMID 21490323 DOI: 10.1212/Wnl.0B013E3182166E96  0.786
2011 Okereke OI, Copeland M, Hyman BT, Wanggaard T, Albert MS, Blacker D. The Structured Interview & Scoring Tool-Massachusetts Alzheimer's Disease Research Center (SIST-M): development, reliability, and cross-sectional validation of a brief structured clinical dementia rating interview. Archives of Neurology. 68: 343-50. PMID 21403019 DOI: 10.1001/Archneurol.2010.375  0.412
2011 Okonkwo OC, Mielke MM, Griffith HR, Moghekar AR, O'Brien RJ, Shaw LM, Trojanowski JQ, Albert MS. Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment. Archives of Neurology. 68: 113-9. PMID 21220682 DOI: 10.1001/Archneurol.2010.334  0.427
2011 Zhu CW, Livote EE, Kahle-Wrobleski K, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Utilization of antihypertensives, antidepressants, antipsychotics, and hormones in Alzheimer disease. Alzheimer Disease and Associated Disorders. 25: 144-8. PMID 20975515 DOI: 10.1097/Wad.0B013E3181Fcba68  0.367
2011 Yassa MA, Lacy JW, Stark SM, Albert MS, Gallagher M, Stark CE. Pattern separation deficits associated with increased hippocampal CA3 and dentate gyrus activity in nondemented older adults. Hippocampus. 21: 968-79. PMID 20865732 DOI: 10.1002/Hipo.20808  0.305
2011 Bakker A, Krauss G, Albert M, Stark C, Bassett S, Gallagher M. P4-349: Clinical efficacy of low dose levetiracetam for hippocampal hyperactivity in amnestic mild cognitive impairment Alzheimer's & Dementia. 7: e34-e34. DOI: 10.1016/J.Jalz.2011.09.095  0.36
2011 Dickerson B, Albert M, Blacker D, Shah R, DeToledo-Morrell L, Killiany R, Sperling R, Stoub T, Hyman B. O1-07-01: Alzheimer's-signature MRI biomarker predicts likelihood of Alzheimer's dementia in cognitively normal adults Alzheimer's & Dementia. 7: S109-S109. DOI: 10.1016/j.jalz.2011.05.272  0.326
2011 Mielke M, Bandaru VVR, Xia J, Haughey N, Yasar S, Albert M, Varma V, Harris G, Schneider E, Bandeen-Roche K, Fried L, Lyketsos C, Carlson M. P3-283: Serum ceramides predict incident Alzheimer's disease: The women's health and aging study (WHAS) II Alzheimer's & Dementia. 7: S607-S607. DOI: 10.1016/J.Jalz.2011.05.1725  0.329
2011 Dickerson B, Stoub T, Shah R, Sperling R, Killiany R, Albert M, Hyman B, Blacker D, DeToledo-Morrell L. IC-P-040: Alzheimer's signature MRI biomarker predicts likelihood of Alzheimer's dementia in cognitively normal adults Alzheimer's & Dementia. 7: S24-S25. DOI: 10.1016/J.Jalz.2011.05.109  0.749
2010 Mielke MM, Haughey NJ, Ratnam Bandaru VV, Schech S, Carrick R, Carlson MC, Mori S, Miller MI, Ceritoglu C, Brown T, Albert M, Lyketsos CG. Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 378-85. PMID 20813340 DOI: 10.1016/J.Jalz.2010.03.014  0.452
2010 Zhu CW, Livote EE, Kahle-Wrobleski K, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Longitudinal medication usage in Alzheimer disease patients. Alzheimer Disease and Associated Disorders. 24: 354-9. PMID 20625271 DOI: 10.1097/Wad.0B013E3181E6A17A  0.425
2010 Jiang L, Kim M, Chodkowski B, Donahue MJ, Pekar JJ, Van Zijl PC, Albert M. Reliability and reproducibility of perfusion MRI in cognitively normal subjects. Magnetic Resonance Imaging. 28: 1283-9. PMID 20573464 DOI: 10.1016/J.Mri.2010.05.002  0.343
2010 Qiu A, Oishi K, Miller MI, Lyketsos CG, Mori S, Albert M. Surface-based analysis on shape and fractional anisotropy of white matter tracts in Alzheimer's disease. Plos One. 5: e9811. PMID 20339558 DOI: 10.1371/Journal.Pone.0009811  0.377
2010 Yassa MA, Stark SM, Bakker A, Albert MS, Gallagher M, Stark CE. High-resolution structural and functional MRI of hippocampal CA3 and dentate gyrus in patients with amnestic Mild Cognitive Impairment. Neuroimage. 51: 1242-52. PMID 20338246 DOI: 10.1016/J.Neuroimage.2010.03.040  0.333
2010 Khachaturian ZS, Barnes D, Einstein R, Johnson S, Lee V, Roses A, Sager MA, Shankle WR, Snyder PJ, Petersen RC, Schellenberg G, Trojanowski J, Aisen P, Albert MS, Breitner JC, et al. Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 89-97. PMID 20298968 DOI: 10.1016/J.Jalz.2010.01.008  0.416
2010 Pihlajamäki M, O' Keefe K, Bertram L, Tanzi RE, Dickerson BC, Blacker D, Albert MS, Sperling RA. Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease. Alzheimer Disease and Associated Disorders. 24: 28-36. PMID 19571734 DOI: 10.1097/Wad.0B013E3181A785C9  0.677
2010 Mielke MM, Okonkwo OC, Mori S, Oishi K, Miller MI, Ceritoglu C, Brown T, Albert M, Lyketsos CG. Fornix fractional anisotropy and hippocampal volume, alone and in combination, predict conversion from MCI to Alzheimer's disease Alzheimer's & Dementia. 6: S288. DOI: 10.1016/J.Jalz.2010.05.948  0.394
2010 Zhu C, Livote E, Kahle-Wrobleski K, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. P2-073: Longitudinal patterns of medication use in Alzheimer's disease Alzheimer's & Dementia. 6: S334-S334. DOI: 10.1016/J.Jalz.2010.05.1119  0.335
2010 Mielke MM, Okonkwo OC, Mori S, Oishi K, Miller MI, Ceritoglu C, Brown T, Albert M, Lyketsos CG. IC-P-031: Fornix fractional anisotropy and hippocampal volume, alone and in combination, predict conversion from MCI to AD Alzheimer's & Dementia. 6: S16-S16. DOI: 10.1016/J.Jalz.2010.05.045  0.347
2009 Brandt J, Aretouli E, Neijstrom E, Samek J, Manning K, Albert MS, Bandeen-Roche K. Selectivity of executive function deficits in mild cognitive impairment. Neuropsychology. 23: 607-18. PMID 19702414 DOI: 10.1037/A0015851  0.414
2009 Scarmeas N, Honig LS, Choi H, Cantero J, Brandt J, Blacker D, Albert M, Amatniek JC, Marder K, Bell K, Hauser WA, Stern Y. Seizures in Alzheimer disease: who, when, and how common? Archives of Neurology. 66: 992-7. PMID 19667221 DOI: 10.1001/Archneurol.2009.130  0.315
2009 Mielke MM, Kozauer NA, Chan KCG, George M, Toroney J, Zerrate M, Bandeen-Roche K, Wang MC, vanZijl P, Pekar JJ, Mori S, Lyketsos CG, Albert M. Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease Neuroimage. 46: 47-55. PMID 19457371 DOI: 10.1016/J.Neuroimage.2009.01.054  0.476
2009 Ceritoglu C, Oishi K, Li X, Chou MC, Younes L, Albert M, Lyketsos C, van Zijl PC, Miller MI, Mori S. Multi-contrast large deformation diffeomorphic metric mapping for diffusion tensor imaging. Neuroimage. 47: 618-27. PMID 19398016 DOI: 10.1016/J.Neuroimage.2009.04.057  0.306
2009 Oishi K, Faria A, Jiang H, Li X, Akhter K, Zhang J, Hsu JT, Miller MI, van Zijl PC, Albert M, Lyketsos CG, Woods R, Toga AW, Pike GB, Rosa-Neto P, et al. Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants. Neuroimage. 46: 486-99. PMID 19385016 DOI: 10.1016/J.Neuroimage.2009.01.002  0.315
2009 Jovicich J, Czanner S, Han X, Salat D, van der Kouwe A, Quinn B, Pacheco J, Albert M, Killiany R, Blacker D, Maguire P, Rosas D, Makris N, Gollub R, Dale A, et al. MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. Neuroimage. 46: 177-92. PMID 19233293 DOI: 10.1016/J.Neuroimage.2009.02.010  0.497
2009 Desikan RS, Cabral HJ, Fischl B, Guttmann CR, Blacker D, Hyman BT, Albert MS, Killiany RJ. Temporoparietal MR imaging measures of atrophy in subjects with mild cognitive impairment that predict subsequent diagnosis of Alzheimer disease. Ajnr. American Journal of Neuroradiology. 30: 532-8. PMID 19112067 DOI: 10.3174/Ajnr.A1397  0.467
2009 Zhu CW, Kahle-Wrobleski K, Livote E, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Longitudinal medication usage in Alzheimer's disease patients Alzheimers & Dementia. 5: 407. DOI: 10.1016/J.Jalz.2009.04.990  0.348
2009 Mielke MM, Haughey N, Bandaru VVR, Miller MI, Mori S, Schech S, Albert M, Lyketsos CG. P3-040: Plasma ceramides predict hippocampal atrophy and progression in memory impairment among amnestic Mild Cognitive Impairment participants Alzheimer's & Dementia. 5: P351-P352. DOI: 10.1016/J.Jalz.2009.04.1217  0.386
2008 Bain LJ, Jedrziewski K, Morrison-Bogorad M, Albert M, Cotman C, Hendrie H, Trojanowski JQ. Healthy brain aging: A meeting report from the Sylvan M. Cohen Annual Retreat of the University of Pennsylvania Institute on Aging Alzheimer's and Dementia. 4: 443-446. PMID 18945646 DOI: 10.1016/J.Jalz.2008.08.006  0.406
2008 Scherer RK, Scarmeas N, Brandt J, Blacker D, Albert MS, Stern Y. The relation of patient dependence to home health aide use in Alzheimer's disease. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 63: 1005-9. PMID 18840808 DOI: 10.1093/Gerona/63.9.1005  0.373
2008 Brickman AM, Honig LS, Scarmeas N, Tatarina O, Sanders L, Albert MS, Brandt J, Blacker D, Stern Y. Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Archives of Neurology. 65: 1202-8. PMID 18779424 DOI: 10.1001/Archneur.65.9.1202  0.456
2008 Desikan RS, Fischl B, Cabral HJ, Kemper TL, Guttmann CR, Blacker D, Hyman BT, Albert MS, Killiany RJ. MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD. Neurology. 71: 819-25. PMID 18672473 DOI: 10.1212/01.Wnl.0000320055.57329.34  0.467
2008 Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, ... ... Albert M, et al. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 156-63. PMID 18631960 DOI: 10.1016/J.Jalz.2008.03.005  0.376
2008 Albert M. Chapter 27 Neuropsychology of Alzheimer's disease Handbook of Clinical Neurology. 88: 511-525. PMID 18631710 DOI: 10.1016/S0072-9752(07)88027-4  0.484
2008 Steinerman JR, Irizarry M, Scarmeas N, Raju S, Brandt J, Albert M, Blacker D, Hyman B, Stern Y. Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study. Archives of Neurology. 65: 906-12. PMID 18625856 DOI: 10.1001/Archneur.65.7.906  0.388
2008 Cosentino S, Scarmeas N, Helzner E, Glymour MM, Brandt J, Albert M, Blacker D, Stern Y. APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology. 70: 1842-9. PMID 18401023 DOI: 10.1212/01.Wnl.0000304038.37421.Cc  0.484
2008 Jack CR, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, L Whitwell J, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DL, Killiany R, ... ... Albert M, et al. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. Journal of Magnetic Resonance Imaging : Jmri. 27: 685-91. PMID 18302232 DOI: 10.1002/Jmri.21049  0.375
2008 Holland CM, Smith EE, Csapo I, Gurol ME, Brylka DA, Killiany RJ, Blacker D, Albert MS, Guttmann CR, Greenberg SM. Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke; a Journal of Cerebral Circulation. 39: 1127-33. PMID 18292383 DOI: 10.1161/Strokeaha.107.497438  0.397
2008 Smith EE, Egorova S, Blacker D, Killiany RJ, Muzikansky A, Dickerson BC, Tanzi RE, Albert MS, Greenberg SM, Guttmann CR. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Archives of Neurology. 65: 94-100. PMID 18195145 DOI: 10.1001/Archneurol.2007.23  0.62
2008 Dickerson BC, Fenstermacher E, Salat DH, Wolk DA, Maguire RP, Desikan R, Pacheco J, Quinn BT, Van der Kouwe A, Greve DN, Blacker D, Albert MS, Killiany RJ, Fischl B. Detection of cortical thickness correlates of cognitive performance: Reliability across MRI scan sessions, scanners, and field strengths. Neuroimage. 39: 10-8. PMID 17942325 DOI: 10.1016/J.Neuroimage.2007.08.042  0.559
2008 Mielke MM, Bandaru VV, Haughey NJ, Schech S, Chu M, Albert M, Bandeen-Roche K, Lyketsos CG. P1-360: Plasma ceramides are altered early in the course of Alzheimer's disease Alzheimer's & Dementia. 4: T324-T324. DOI: 10.1016/J.Jalz.2008.05.942  0.343
2008 Blacker D, Wanggaard T, Copeland M, Betensky R, Hyman BT, Albert MS, Okereke OI. P1-180: Reliability and predictive validity of questionnaire items for development of a brief, structured clinical dementia rating interview Alzheimer's & Dementia. 4: T261-T261. DOI: 10.1016/J.Jalz.2008.05.768  0.303
2008 Zhu C, Leibman C, McLaughlin T, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. O2-07-05: Patient dependence, function, and changes in cost of care in Alzheimer's disease Alzheimer's & Dementia. 4: T147-T147. DOI: 10.1016/J.Jalz.2008.05.362  0.308
2008 Yassa MA, Albert MS, Gallagher M, Stark CE. IC-P1-069: Functional MRI of hippocampal subfields in healthy aging and Mild Cognitive Impairment Alzheimer's & Dementia. 4: T36-T36. DOI: 10.1016/J.Jalz.2008.05.2511  0.364
2008 Zhu C, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. AbstractPoster presentation: Tuesday posterP3-442: Comparison of costs of care between patients with Alzheimer's disease and dementia with Lewy bodies Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.2012  0.357
2007 Scarmeas N, Brandt J, Blacker D, Albert M, Hadjigeorgiou G, Dubois B, Devanand D, Honig L, Stern Y. Disruptive behavior as a predictor in Alzheimer disease. Archives of Neurology. 64: 1755-61. PMID 18071039 DOI: 10.1001/Archneur.64.12.1755  0.443
2007 Dickerson BC, Sperling RA, Hyman BT, Albert MS, Blacker D. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Archives of General Psychiatry. 64: 1443-50. PMID 18056553 DOI: 10.1001/Archpsyc.64.12.1443  0.689
2007 Albert MS. Changing the trajectory of cognitive decline? The New England Journal of Medicine. 357: 502-3. PMID 17671260 DOI: 10.1056/Nejmcibr073273  0.321
2007 Dickerson BC, Miller SL, Greve DN, Dale AM, Albert MS, Schacter DL, Sperling RA. Prefrontal-hippocampal-fusiform activity during encoding predicts intraindividual differences in free recall ability: an event-related functional-anatomic MRI study. Hippocampus. 17: 1060-70. PMID 17604356 DOI: 10.1002/Hipo.20338  0.592
2007 McQueen MB, Bertram L, Lange C, Becker KD, Albert MS, Tanzi RE, Blacker D. Exploring candidate gene associations with neuropsychological performance. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 144: 987-91. PMID 17579348 DOI: 10.1002/Ajmg.B.30500  0.433
2007 Blacker D, Lee H, Muzikansky A, Martin EC, Tanzi R, McArdle JJ, Moss M, Albert M. Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Archives of Neurology. 64: 862-71. PMID 17562935 DOI: 10.1001/Archneur.64.6.862  0.463
2007 Albert M, Blacker D, Moss MB, Tanzi R, McArdle JJ. Longitudinal change in cognitive performance among individuals with mild cognitive impairment. Neuropsychology. 21: 158-69. PMID 17402816 DOI: 10.1037/0894-4105.21.2.158  0.412
2007 Moscarillo TJ, Holt H, Perman M, Goldberg S, Cortellini L, Stoler JM, DeJong W, Miles BJ, Albert MS, Go RC, Blacker D. Knowledge of and attitudes about Alzheimer disease genetics: report of a pilot survey and two focus groups. Community Genetics. 10: 97-102. PMID 17380059 DOI: 10.1159/000099087  0.363
2007 Johnson KA, Moran EK, Becker JA, Blacker D, Fischman AJ, Albert MS. Single photon emission computed tomography perfusion differences in mild cognitive impairment. Journal of Neurology, Neurosurgery, and Psychiatry. 78: 240-7. PMID 17056633 DOI: 10.1136/Jnnp.2006.096800  0.389
2007 Desikan RS, Fischl B, Cabral HJ, Kemper TL, Guttmann CR, Blacker D, Hyman BT, Albert MS, Killiany RJ. P-030: MRI-based longitudinal measures of temporoparietal regions show differential rates of atrophy during prodromal Alzheimer's disease Alzheimer's & Dementia. 3: S106-S106. DOI: 10.1016/J.Jalz.2007.04.246  0.384
2007 Albert M. PL3-01: Lifestyle factors & cognitive decline Alzheimers & Dementia. 3. DOI: 10.1016/J.Jalz.2007.04.014  0.358
2006 Hendrie HC, Albert MS, Butters MA, Gao S, Knopman DS, Launer LJ, Yaffe K, Cuthbert BN, Edwards E, Wagster MV. The NIH Cognitive and Emotional Health Project. Report of the Critical Evaluation Study Committee. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 12-32. PMID 19595852 DOI: 10.1016/J.Jalz.2005.11.004  0.351
2006 Albert MS, Blacker D. Mild cognitive impairment and dementia. Annual Review of Clinical Psychology. 2: 379-88. PMID 17716075 DOI: 10.1146/Annurev.Clinpsy.1.102803.144039  0.413
2006 Stavitsky K, Brickman AM, Scarmeas N, Torgan RL, Tang MX, Albert M, Brandt J, Blacker D, Stern Y. The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease. Archives of Neurology. 63: 1450-6. PMID 17030662 DOI: 10.1001/Archneur.63.10.1450  0.467
2006 Celone KA, Calhoun VD, Dickerson BC, Atri A, Chua EF, Miller SL, DePeau K, Rentz DM, Selkoe DJ, Blacker D, Albert MS, Sperling RA. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 10222-31. PMID 17021177 DOI: 10.1523/Jneurosci.2250-06.2006  0.682
2006 Espeland MA, Rapp SR, Robertson J, Granek I, Murphy C, Albert M, Bassford TL. Benchmarks for designing two-stage studies using modified mini-mental state examinations: experience from the Women's Health Initiative Memory Study Clinical Trials. 3: 99-106. PMID 16773952 DOI: 10.1191/1740774506Cn140Oa  0.333
2006 Amatniek JC, Hauser WA, DelCastillo-Castaneda C, Jacobs DM, Marder K, Bell K, Albert M, Brandt J, Stern Y. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia. 47: 867-72. PMID 16686651 DOI: 10.1111/J.1528-1167.2006.00554.X  0.334
2006 Han X, Jovicich J, Salat D, van der Kouwe A, Quinn B, Czanner S, Busa E, Pacheco J, Albert M, Killiany R, Maguire P, Rosas D, Makris N, Dale A, Dickerson B, et al. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage. 32: 180-94. PMID 16651008 DOI: 10.1016/J.Neuroimage.2006.02.051  0.505
2006 Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 31: 968-80. PMID 16530430 DOI: 10.1016/J.Neuroimage.2006.01.021  0.507
2006 Holtzer R, Irizarry MC, Sanders J, Hyman BT, Wegesin DJ, Riba A, Brandt J, Albert M, Stern Y. Relation of quantitative indexes of concurrent alpha-synuclein abnormalities to clinical outcome in autopsy-proven Alzheimer disease. Archives of Neurology. 63: 226-30. PMID 16476811 DOI: 10.1001/Archneur.63.2.226  0.46
2006 Zaitchik D, Koff E, Brownell H, Winner E, Albert M. Inference of beliefs and emotions in patients with Alzheimer's disease. Neuropsychology. 20: 11-20. PMID 16460218 DOI: 10.1037/0894-4105.20.1.11  0.358
2006 Rand-Giovannetti E, Chua EF, Driscoll AE, Schacter DL, Albert MS, Sperling RA. Hippocampal and neocortical activation during repetitive encoding in older persons. Neurobiology of Aging. 27: 173-82. PMID 16298252 DOI: 10.1016/J.Neurobiolaging.2004.12.013  0.5
2006 Soldan A, Pettigrew C, Zhu Y, Singh B, Fletcher E, Martinez O, Wang M, DeCarli CS, Albert MS. O2-13-04: WHITE MATTER HYPERINTENSITIES AND CSF BIOMARKERS IN RELATION TO CLINICAL SYMPTOM ONSET IN PRECLINICAL ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P654-P654. DOI: 10.1016/J.Jalz.2018.06.2715  0.347
2006 Pettigrew C, Wu D, Soldan A, Oishi K, Miller M, Mori S, Albert MS. P2-432: REGIONAL WHITE MATTER HYPERINTENSITIES ARE DIFFERENTIALLY RELATED TO MEASURES OF VASCULAR RISK AND ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P878-P878. DOI: 10.1016/J.Jalz.2018.06.1124  0.364
2006 Dickerson BC, Hevelone N, Sperling RA, Albert MS, Blacker D. P2-073: Prediction of cognitive decline among very mild MCI cases Alzheimer's & Dementia. 2: S254-S254. DOI: 10.1016/J.Jalz.2006.05.910  0.631
2006 Pihlajamaki M, Miller SM, DePeau KM, Celone KA, Bertram L, Tanzi RE, Dickerson BC, Albert MS, Blacker D, Sperling RA. O4-01-02: The effect of APOE-4 on fMRI deactivation in older controls, MCI subjects and AD patients Alzheimer's & Dementia. 2: S74-S75. DOI: 10.1016/J.Jalz.2006.05.292  0.624
2006 Sperling R, Depeau K, Miller S, Chua E, Rentz D, Dickerson B, Atri A, Selkoe D, Johnson K, Calhoun V, Albert M, Celone K. Ic-101-05 Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.2344  0.52
2006 Honig LS, Scarmeas N, Brickman AM, Albert MS, Brandt J, Blacker D, Stern Y. IC-P-123: Greater cerebral atrophy predicts more rapid cognitive decline in Alzheimer's disease Alzheimer's & Dementia. 2: S701-S702. DOI: 10.1016/J.Jalz.2006.05.2329  0.429
2006 DePeau KM, Pihlajamaki M, Diamond EL, Miller SM, Chua EF, Dickerson BC, Albert MS, Blacker D, Sperling RA. IC-P-086: Failure of hippocampal habituation in mild cognitive impairment and Alzheimer's disease Alzheimer's & Dementia. 2: S687-S688. DOI: 10.1016/J.Jalz.2006.05.2291  0.556
2006 Desikan RS, Han X, Cabral HJ, Fischl B, Blacker D, Guttmann CR, Albert MS, Killiany RJ. IC-P-082: Atrophy in the parietotemporal regions increases the risk of developing Alzheimer's disease: A longitudinal MRI study Alzheimer's & Dementia. 2: S686-S686. DOI: 10.1016/J.Jalz.2006.05.2287  0.369
2006 Pihlajamaki M, Miller SM, DePeau KM, Celone KA, Bertram L, Tanzi RE, Dickerson BC, Albert MS, Blacker D, Sperling RA. IC-P-071: The effect of APOE-4 on fMRI deactivation in older controls, MCI subjects and AD patients Alzheimer's & Dementia. 2: S681-S681. DOI: 10.1016/J.Jalz.2006.05.2276  0.63
2006 Irizarry MC, Muzikansky A, Lee H, Raju S, Bottiglieri T, Hyman BT, Albert MS, Deborah B. AbstractPoster presentation: Tuesday posterP3-100: Longitudinal changes in plasma Aβ42 positively correlate with progression of mild cognitive impairment Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1367  0.384
2006 Desikan RS, Han X, Cabral HJ, Fischl B, Blacker D, Guttmann CR, Albert MS, Killiany RJ. P2-368: Atrophy in the parietotemporal regions increases the risk of developing Alzheimer's disease: A longitudinal MRI study Alzheimer's & Dementia. 2: S352-S352. DOI: 10.1016/J.Jalz.2006.05.1208  0.388
2006 Smith EE, Egorova S, Blacker D, Killiany R, Muzikansky A, Dickerson BC, Tanzi RE, Albert MS, Greenberg SM, Guttman CRG. IC-P-118: Vascular risks and MRI measures of white matter hyperintensities and brain atrophy in the prediction of cognitive decline Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1197  0.357
2006 Sperling R, Depeau K, Miller S, Chua E, Dorene R, Dickerson B, Atri A, Selkoe D, Albert M, Calhoun V, Celone K. P2-302: FMRI alterations medial temporal and neocortical networks in MCI and AD Alzheimer's & Dementia. 2: S328-S329. DOI: 10.1016/J.Jalz.2006.05.1142  0.619
2006 Honig LS, Scarmeas N, Brickman AM, Albert MS, Brandt J, Blacker D, Stern Y. P2-266: Greater cerebral atrophy predicts more rapid cognitive decline in Alzheimer's disease Alzheimer's & Dementia. 2: S316-S316. DOI: 10.1016/J.Jalz.2006.05.1105  0.451
2005 Holtzer R, Scarmeas N, Wegesin DJ, Albert M, Brandt J, Dubois B, Hadjigeorgiou GM, Stern Y. Depressive symptoms in Alzheimer's disease: natural course and temporal relation to function and cognitive status. Journal of the American Geriatrics Society. 53: 2083-9. PMID 16398891 DOI: 10.1111/J.1532-5415.2005.00535.X  0.385
2005 Scarmeas N, Brandt J, Albert M, Hadjigeorgiou G, Papadimitriou A, Dubois B, Sarazin M, Devanand D, Honig L, Marder K, Bell K, Wegesin D, Blacker D, Stern Y. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Archives of Neurology. 62: 1601-8. PMID 16216946 DOI: 10.1001/Archneur.62.10.1601  0.441
2005 Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, Bertram L, Mullin K, Tanzi RE, Blacker D, Albert MS, Sperling RA. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology. 65: 404-11. PMID 16087905 DOI: 10.1212/01.Wnl.0000171450.97464.49  0.696
2005 Wedig MM, Rauch SL, Albert MS, Wright CI. Differential amygdala habituation to neutral faces in young and elderly adults. Neuroscience Letters. 385: 114-9. PMID 15961229 DOI: 10.1016/J.Neulet.2005.05.039  0.318
2005 Scarmeas N, Albert M, Brandt J, Blacker D, Hadjigeorgiou G, Papadimitriou A, Dubois B, Sarazin M, Wegesin D, Marder K, Bell K, Honig L, Stern Y. Motor signs predict poor outcomes in Alzheimer disease. Neurology. 64: 1696-703. PMID 15911793 DOI: 10.1212/01.Wnl.0000162054.15428.E9  0.399
2005 Sarazin M, Stern Y, Berr C, Riba A, Albert M, Brandt J, Dubois B. Neuropsychological predictors of dependency in patients with Alzheimer disease. Neurology. 64: 1027-31. PMID 15781821 DOI: 10.1212/01.Wnl.0000154529.53488.30  0.476
2005 Dickerson BC, Salat DH, Greve DN, Albert MS, Blacker D, Sperling RA. [P-095]: An fMRI investigation of memory-related medial temporal lobe activation in mild cognitive impairment prior to dementia Alzheimer's & Dementia. 1: S38-S38. DOI: 10.1016/J.Jalz.2005.06.169  0.664
2004 Zaitchik D, Koff E, Brownell H, Winner E, Albert M. Inference of mental states in patients with Alzheimer's disease. Cognitive Neuropsychiatry. 9: 301-13. PMID 16571588 DOI: 10.1080/13546800344000246  0.398
2004 McArdle JJ, Hamgami F, Jones K, Jolesz F, Kikinis R, Spiro A, Albert MS. Structural modeling of dynamic changes in memory and brain structure using longitudinal data from the normative aging study. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. 59: P294-304. PMID 15576857 DOI: 10.1093/Geronb/59.6.P294  0.3
2004 Lyketsos CG, Brandt J, Fishman P, Gloth M, Koliatsos V, Loreck D, McGuire M, Rabins PV, Wertheimer D, Schwartz J, Das A, Sachs G, Albert M, McConnell S, Thies W. Research consent for cognitively impaired adults: Recommendations for Institutional Review Boards and investigators Alzheimer Disease and Associated Disorders. 18: 171-175. PMID 15494623 DOI: 10.1097/01.Wad.0000137520.23370.56  0.377
2004 Chua EF, Rand-Giovannetti E, Schacter DL, Albert MS, Sperling RA. Dissociating confidence and accuracy: functional magnetic resonance imaging shows origins of the subjective memory experience. Journal of Cognitive Neuroscience. 16: 1131-42. PMID 15453969 DOI: 10.1162/0898929041920568  0.468
2004 Scarmeas N, Hadjigeorgiou GM, Papadimitriou A, Dubois B, Sarazin M, Brandt J, Albert M, Marder K, Bell K, Honig LS, Wegesin D, Stern Y. Motor signs during the course of Alzheimer disease. Neurology. 63: 975-82. PMID 15452286 DOI: 10.1212/01.Wnl.0000138440.39918.0C  0.389
2004 Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, et al. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine. 256: 240-6. PMID 15324367 DOI: 10.1111/J.1365-2796.2004.01380.X  0.408
2004 Dickerson BC, Salat DH, Bates JF, Atiya M, Killiany RJ, Greve DN, Dale AM, Stern CE, Blacker D, Albert MS, Sperling RA. Medial temporal lobe function and structure in mild cognitive impairment. Annals of Neurology. 56: 27-35. PMID 15236399 DOI: 10.1002/Ana.20163  0.664
2004 Ingelsson M, Fukumoto H, Newell KL, Growdon JH, Hedley-Whyte ET, Frosch MP, Albert MS, Hyman BT, Irizarry MC. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology. 62: 925-31. PMID 15037694 DOI: 10.1212/01.Wnl.0000115115.98960.37  0.387
2004 Lange N, Lake S, Sperling R, Brown J, Routledge C, Albert M, Heckers S. Two macroscopic and microscopic brain imaging studies of human hippocampus in early Alzheimer's disease and schizophrenia research. Statistics in Medicine. 23: 327-50. PMID 14716733 DOI: 10.1002/Sim.1720  0.498
2004 Sperling R, Dickerson B, Rand-Giovannetti E, Chua EF, Driscoll AE, Rentz D, Blacker D, Albert MS. P3-100 Increased medial temporal lobe FMRI activation in questionable AD compared to normal aging Neurobiology of Aging. 25: S383. DOI: 10.1016/S0197-4580(04)81252-1  0.626
2004 Honig LS, Scarmeas N, Riba A, Albert M, Brandt J, Stern Y. P3-090 MRI signal hyperintensities predict more rapid cognitive decline in Alzheimer's disease (AD) Neurobiology of Aging. 25: S379. DOI: 10.1016/S0197-4580(04)81242-9  0.471
2004 Desikan RS, Fischl B, Dale AM, Salat DH, Makris N, Buckner RL, Albert MS, Killiany R. P3-081 Development of automated identification of cortical regions on MRI scans in AD patients Neurobiology of Aging. 25: S376. DOI: 10.1016/S0197-4580(04)81233-8  0.366
2004 Irizarry MC, Fukumoto H, Daly E, Gunther J, Hyman BT, Albert MS, Blacker D. P3-009 Cross-sectional measures of plasma amyloid-beta protein do not correlate with functional status in prodromal Alzheimer's disease Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81164-3  0.324
2004 Johnson KA, Moran EK, Becker JA, Killiany R, Blacker D, Fischman AL, Albert M. P2-240 Prediction of clinical stability vs. progression in questionable ad using perfusion spect Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80986-2  0.344
2004 Dickerson BC, Salat DH, Bates JF, Atiya M, Killiany RJ, Greve DN, Dale AM, Stern CE, Blacker D, Albert MS, Sperling RA. P2-165 Functional and structural MRI in questionable AD: relationships to clinical impairment and future decline Neurobiology of Aging. 25: S272-S273. DOI: 10.1016/S0197-4580(04)80912-6  0.641
2004 Zaitchik D, Fitzpatrick K, Albert M. P1-057 Concepts of living things in patients with Alzheimer's disease Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80371-3  0.375
2003 Sperling R, Chua E, Cocchiarella A, Rand-Giovannetti E, Poldrack R, Schacter DL, Albert M. Putting names to faces: successful encoding of associative memories activates the anterior hippocampal formation. Neuroimage. 20: 1400-10. PMID 14568509 DOI: 10.1016/S1053-8119(03)00391-4  0.454
2003 Atiya M, Hyman BT, Albert MS, Killiany R. Structural magnetic resonance imaging in established and prodromal Alzheimer disease: a review. Alzheimer Disease and Associated Disorders. 17: 177-95. PMID 14512832 DOI: 10.1097/00002093-200307000-00010  0.417
2003 Saunders AJ, Bertram L, Mullin K, Sampson AJ, Latifzai K, Basu S, Jones J, Kinney D, MacKenzie-Ingano L, Yu S, Albert MS, Moscarillo TJ, Go RC, Bassett SS, Daly MJ, et al. Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin. Human Molecular Genetics. 12: 2765-76. PMID 12966032 DOI: 10.1093/Hmg/Ddg310  0.354
2003 Holtzer R, Wegesin DJ, Albert SM, Marder K, Bell K, Albert M, Brandt J, Stern Y. The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer disease. Archives of Neurology. 60: 1137-42. PMID 12925372 DOI: 10.1001/Archneur.60.8.1137  0.451
2003 El Fakhri G, Kijewski MF, Johnson KA, Syrkin G, Killiany RJ, Becker JA, Zimmerman RE, Albert MS. MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease. Archives of Neurology. 60: 1066-72. PMID 12925361 DOI: 10.1001/Archneur.60.8.1066  0.415
2003 Holtzer R, Tang MX, Devanand DP, Albert SM, Wegesin DJ, Marder K, Bell K, Albert M, Brandt J, Stern Y. Psychopathological features in Alzheimer's disease: course and relationship with cognitive status. Journal of the American Geriatrics Society. 51: 953-60. PMID 12834515 DOI: 10.1046/J.1365-2389.2003.51308.X  0.455
2003 Albert MS. Detection of very early Alzheimer disease through neuroimaging. Alzheimer Disease and Associated Disorders. 17: S63-5. PMID 12813213 DOI: 10.1097/00002093-200304002-00010  0.365
2003 Bretsky P, Guralnik JM, Launer L, Albert M, Seeman TE. The role of APOE-ε4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging Neurology. 60: 1077-1081. PMID 12682309 DOI: 10.1212/01.Wnl.0000055875.26908.24  0.423
2003 Copeland MP, Daly E, Hines V, Mastromauro C, Zaitchik D, Gunther J, Albert M. Psychiatric symptomatology and prodromal Alzheimer's disease. Alzheimer Disease and Associated Disorders. 17: 1-8. PMID 12621314 DOI: 10.1097/00002093-200301000-00001  0.385
2003 Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, Perry RT, Collins JS, Harrell LE, Go RC, Mahoney A, Beaty T, Fallin MD, Avramopoulos D, Chase GA, et al. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Human Molecular Genetics. 12: 23-32. PMID 12490529 DOI: 10.1093/Hmg/Ddg007  0.332
2003 Sperling RA, Bates JF, Chua EF, Cocchiarella AJ, Rentz DM, Rosen BR, Schacter DL, Albert MS. fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 74: 44-50. PMID 12486265 DOI: 10.1136/Jnnp.74.1.44  0.532
2002 Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology. 59: 371-8. PMID 12177370 DOI: 10.1212/Wnl.59.3.371  0.341
2002 Brickman AM, Riba A, Bell K, Marder K, Albert M, Brandt J, Stern Y. Longitudinal assessment of patient dependence in Alzheimer disease Archives of Neurology. 59: 1304-1308. PMID 12164728 DOI: 10.1001/Archneur.59.8.1304  0.399
2002 Chodosh J, Reuben DB, Albert MS, Seeman TE. Predicting cognitive impairment in high-functioning community-dwelling older persons: MacArthur Studies of Successful Aging. Journal of the American Geriatrics Society. 50: 1051-60. PMID 12110065 DOI: 10.1046/J.1532-5415.2002.50260.X  0.423
2002 Fillit HM, Butler RN, O'Connell AW, Albert MS, Birren JE, Cotman CW, Greenough WT, Gold PE, Kramer AF, Kuller LH, Perls TT, Sahagan BG, Tully T. Achieving and maintaining cognitive vitality with aging. Mayo Clinic Proceedings. 77: 681-96. PMID 12108606 DOI: 10.4065/77.7.681  0.595
2002 Killiany RJ, Hyman BT, Gomez-Isla T, Moss MB, Kikinis R, Jolesz F, Tanzi R, Jones K, Albert MS. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology. 58: 1188-96. PMID 11971085 DOI: 10.1212/Wnl.58.8.1188  0.425
2002 Scarmeas N, Brandt J, Albert M, Devanand DP, Marder K, Bell K, Ciappa A, Tycko B, Stern Y. Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology. 58: 1182-8. PMID 11971084 DOI: 10.1212/Wnl.58.8.1182  0.416
2002 Albert MS. Memory decline: the boundary between aging and age-related disease. Annals of Neurology. 51: 282-4. PMID 11891821 DOI: 10.1002/Ana.10156  0.302
2002 Sperling R, Greve D, Dale A, Killiany R, Holmes J, Rosas HD, Cocchiarella A, Firth P, Rosen B, Lake S, Lange N, Routledge C, Albert M. Functional MRI detection of pharmacologically induced memory impairment. Proceedings of the National Academy of Sciences of the United States of America. 99: 455-60. PMID 11756667 DOI: 10.1073/Pnas.012467899  0.479
2001 McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Archives of Neurology. 58: 1803-9. PMID 11708987 DOI: 10.1001/Archneur.58.11.1803  0.374
2001 Sperling RA, Bates JF, Cocchiarella AJ, Schacter DL, Rosen BR, Albert MS. Encoding novel face-name associations: a functional MRI study. Human Brain Mapping. 14: 129-39. PMID 11559958 DOI: 10.1002/Hbm.1047  0.466
2001 Ramos LR, Simoes EJ, Albert MS. Dependence in activities of daily living and cognitive impairment strongly predicted mortality in older urban residents in Brazil: a 2-year follow-up. Journal of the American Geriatrics Society. 49: 1168-75. PMID 11559375 DOI: 10.1046/J.1532-5415.2001.49233.X  0.353
2001 Seeman TE, Lusignolo TM, Albert M, Berkman L. Social relationships, social support, and patterns of cognitive aging in healthy, high-functioning older adults: MacArthur studies of successful aging. Health Psychology. 20: 243-255. PMID 11515736 DOI: 10.1037/0278-6133.20.4.243  0.374
2001 Albert MS, Moss MB, Tanzi R, Jones K. Preclinical prediction of AD using neuropsychological tests. Journal of the International Neuropsychological Society : Jins. 7: 631-9. PMID 11459114 DOI: 10.1017/S1355617701755105  0.423
2001 Johnson KA, Lopera F, Jones K, Becker A, Sperling R, Hilson J, Londono J, Siegert I, Arcos M, Moreno S, Madrigal L, Ossa J, Pineda N, Ardila A, Roselli M, ... Albert MS, et al. Presenilin-1-associated abnormalities in regional cerebral perfusion. Neurology. 56: 1545-51. PMID 11402113 DOI: 10.1212/Wnl.56.11.1545  0.502
2001 Daly E, Komaroff AL, Bloomingdale K, Wilson S, Albert MS. Neuropsychological function in patients with chronic fatigue syndrome, multiple sclerosis, and depression. Applied Neuropsychology. 8: 12-22. PMID 11388119 DOI: 10.1207/S15324826An0801_3  0.32
2001 Sperling R, Greve D, Dale A, Killiany R, Rosen B, Holmes J, Rosas H, Cocchiarella A, Firth P, Lange N, Routledge C, Albert M. Effects of lorazepam and scopolamine on encoding face-name associations: A pharmacologic fMRI trial Neuroimage. 13: 743. DOI: 10.1016/S1053-8119(01)92085-3  0.467
2000 Collins JS, Perry RT, Watson B, Harrell LE, Acton RT, Blacker D, Albert MS, Tanzi RE, Bassett SS, McInnis MG, Campbell RD, Go RC. Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative. American Journal of Medical Genetics. 96: 823-30. PMID 11121190 DOI: 10.1002/1096-8628(20001204)96:6<823::Aid-Ajmg26>3.0.Co;2-I  0.36
2000 Albert MS, Drachman DA. Alzheimer's disease: what is it, how many people have it, and why do we need to know? Neurology. 55: 166-8. PMID 10908884 DOI: 10.1212/Wnl.55.2.166  0.456
2000 Grodstein F, Chen J, Pollen DA, Albert MS, Wilson RS, Folstein MF, Evans DA, Stampfer MJ. Postmenopausal hormone therapy and cognitive function in healthy older women. Journal of the American Geriatrics Society. 48: 746-52. PMID 10894312 DOI: 10.1111/J.1532-5415.2000.Tb04748.X  0.372
2000 Johnson KA, Albert MS. Perfusion abnormalities in prodromal AD. Neurobiology of Aging. 21: 289-92. PMID 10867213 DOI: 10.1016/S0197-4580(00)00137-8  0.42
2000 Daly E, Zaitchik D, Copeland M, Schmahmann J, Gunther J, Albert M. Predicting conversion to Alzheimer disease using standardized clinical information. Archives of Neurology. 57: 675-80. PMID 10815133 DOI: 10.1001/Archneur.57.5.675  0.429
2000 Killiany RJ, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F, Tanzi R, Jones K, Hyman BT, Albert MS. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Annals of Neurology. 47: 430-9. PMID 10762153 DOI: 10.1002/1531-8249(200004)47:4<430::Aid-Ana5>3.0.Co;2-I  0.448
2000 Albert MS, Moss MB, Jones K. Early detection of Alzheimer's disease using neuropsychological testing Neurobiology of Aging. 21: 73. DOI: 10.1016/S0197-4580(00)82550-6  0.367
1999 Gómez-Tortosa E, Newell K, Irizarry MC, Albert M, Growdon JH, Hyman BT. Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology. 53: 1284-91. PMID 10522886 DOI: 10.1212/Wnl.53.6.1284  0.383
1999 Wilson RS, Beckett LA, Bennett DA, Albert MS, Evans DA. Change in cognitive function in older persons from a community population: relation to age and Alzheimer disease. Archives of Neurology. 56: 1274-9. PMID 10520945 DOI: 10.1001/Archneur.56.10.1274  0.463
1999 Jacobs DM, Albert SM, Sano M, del Castillo-Castañeda C, Paik MC, Marder K, Bell K, Brandt J, Albert MS, Stern Y. Assessment of cognition in advanced AD: the test for severe impairment. Neurology. 52: 1689-91. PMID 10331701 DOI: 10.1212/Wnl.52.8.1689  0.434
1999 Koff E, Zaitchik D, Montepare J, Albert MS. Emotion processing in the visual and auditory domains by patients with Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 5: 32-40. PMID 9989022 DOI: 10.1017/S1355617799511053  0.31
1999 Wilson RS, Beckett LA, Bennett DA, Albert MS, Evans DA. Change in cognitive function in older persons from a community population: Relation to age and Alzheimer disease Archives of Neurology. 56: 1274-1279. DOI: 10.1001/archneur.56.10.1274  0.358
1998 Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 51: 1546-54. PMID 9855500 DOI: 10.1212/Wnl.51.6.1546  0.322
1998 Liao A, Nitsch RM, Greenberg SM, Finckh U, Blacker D, Albert M, Rebeck GW, Gomez-Isla T, Clatworthy A, Binetti G, Hock C, Mueller-Thomsen T, Mann U, Zuchowski K, Beisiegel U, et al. Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Human Molecular Genetics. 7: 1953-6. PMID 9811940 DOI: 10.1093/Hmg/7.12.1953  0.376
1998 Mohs RC, Ashman TA, Jantzen K, Albert M, Brandt J, Gordon B, Rasmusson X, Grossman M, Jacobs D, Stern Y. A study of the efficacy of a comprehensive memory enhancement program in healthy elderly persons. Psychiatry Research. 77: 183-95. PMID 9707301 DOI: 10.1016/S0165-1781(98)00003-1  0.307
1998 Blacker D, Wilcox MA, Laird NM, Rodes L, Horvath SM, Go RC, Perry R, Watson B, Bassett SS, McInnis MG, Albert MS, Hyman BT, Tanzi RE. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nature Genetics. 19: 357-60. PMID 9697696 DOI: 10.1038/1243  0.372
1998 Johnson KA, Jones K, Holman BL, Becker JA, Spiers PA, Satlin A, Albert MS. Preclinical prediction of Alzheimer's disease using SPECT. Neurology. 50: 1563-71. PMID 9633695 DOI: 10.1212/Wnl.50.6.1563  0.435
1997 Go RC, Duke LW, Harrell LE, Cody H, Bassett SS, Folstein MF, Albert MS, Foster JL, Sharrow NA, Blacker D. Development and validation of a Structured Telephone Interview for Dementia Assessment (STIDA): the NIMH Genetics Initiative. Journal of Geriatric Psychiatry and Neurology. 10: 161-7. PMID 9453683 DOI: 10.1177/089198879701000407  0.439
1997 Albert MS. The ageing brain: normal and abnormal memory. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 352: 1703-9. PMID 9415922 DOI: 10.1098/Rstb.1997.0152  0.389
1997 Evans DA, Hebert LE, Beckett LA, Scherr PA, Albert MS, Chown MJ, Pilgrim DM, Taylor JO. Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. Archives of Neurology. 54: 1399-405. PMID 9362989 DOI: 10.1001/Archneur.1997.00550230066019  0.371
1997 Albert SM, Sano M, Marder K, Jacobs DM, Brandt J, Albert M, Stern Y. Participation in clinical trials and long-term outcomes in Alzheimer's disease. Neurology. 49: 38-43. PMID 9222167 DOI: 10.1212/Wnl.49.1.38  0.339
1997 Stern Y, Brandt J, Albert M, Jacobs DM, Liu X, Bell K, Marder K, Sano M, Albert S, Del-Castillo Castenada C, Bylsma F, Tycko B, Mayeux R. The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease. Annals of Neurology. 41: 615-20. PMID 9153523 DOI: 10.1002/Ana.410410510  0.401
1997 Costa P.T. J, Williams TF, Albert MS, Butters NM, Folstein MF, Gilman S, Gurland BJ, Gwyther LP, Heyman A, Kaszniak AW, Katz IR, Lanska D, Levy LL, Lombardo NE, Orr-Rainey NK, et al. Early identification of Alzheimer's disease and related dementias American Family Physician. 55: 1303-1314. PMID 9092291 DOI: 10.1111/j.1745-7599.1997.tb01024.x  0.305
1997 Devanand DP, Jacobs DM, Tang MX, Del Castillo-Castaneda C, Sano M, Marder K, Bell K, Bylsma FW, Brandt J, Albert M, Stern Y. The course of psychopathologic features in mild to moderate Alzheimer disease. Archives of General Psychiatry. 54: 257-63. PMID 9075466 DOI: 10.1001/Archpsyc.1997.01830150083012  0.378
1997 Albert MS. The science of the mind. Science (New York, N.Y.). 275: 1547. PMID 9072814 DOI: 10.1126/Science.275.5306.1547  0.461
1997 Stern Y, Tang MX, Albert MS, Brandt J, Jacobs DM, Bell K, Marder K, Sano M, Devanand D, Albert SM, Bylsma F, Tsai WY. Predicting time to nursing home care and death in individuals with Alzheimer disease. Jama. 277: 806-12. PMID 9052710 DOI: 10.1001/Jama.1997.03540340040030  0.336
1997 Blacker D, Haines JL, Rodes L, Terwedow H, Go RC, Harrell LE, Perry RT, Bassett SS, Chase G, Meyers D, Albert MS, Tanzi R. ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology. 48: 139-47. PMID 9008509 DOI: 10.1212/Wnl.48.1.139  0.421
1996 Albert MS. Cognitive and neurobiologic markers of early Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 93: 13547-51. PMID 8942970 DOI: 10.1073/Pnas.93.24.13547  0.478
1996 Stern Y, Liu X, Albert M, Brandt J, Jacobs DM, Del Castillo-Castaneda C, Marder K, Bell K, Sano M, Bylsma F. Modeling the influence of extrapyramidal signs on the progression of Alzheimer disease. Archives of Neurology. 53: 1121-6. PMID 8912485 DOI: 10.1001/Archneur.1996.00550110061013  0.378
1996 Albert SM, Del Castillo-Castaneda C, Sano M, Jacobs DM, Marder K, Bell K, Bylsma F, Lafleche G, Brandt J, Albert M, Stern Y. Quality of life in patients with Alzheimer's disease as reported by patient proxies. Journal of the American Geriatrics Society. 44: 1342-7. PMID 8909350 DOI: 10.1111/J.1532-5415.1996.Tb01405.X  0.303
1996 Marcel B, Komaroff AL, Fagioli LR, Kornish RJ, Albert MS. Cognitive deficits in patients with chronic fatigue syndrome. Biological Psychiatry. 40: 535-41. PMID 8879474 DOI: 10.1016/0006-3223(95)00422-X  0.319
1996 Matsumae M, Kikinis R, Mórocz I, Lorenzo AV, Albert MS, Black PM, Jolesz FA. Intracranial compartment volumes in patients with enlarged ventricles assessed by magnetic resonance-based image processing. Journal of Neurosurgery. 84: 972-81. PMID 8847592 DOI: 10.3171/Jns.1996.84.6.0972  0.328
1996 Peters A, Rosene DL, Moss MB, Kemper TL, Abraham CR, Tigges J, Albert MS. Neurobiological bases of age-related cognitive decline in the rhesus monkey. Journal of Neuropathology and Experimental Neurology. 55: 861-74. PMID 8759775 DOI: 10.1097/00005072-199608000-00001  0.367
1996 Ott BR, Lafleche G, Whelihan WM, Buongiorno GW, Albert MS, Fogel BS. Impaired awareness of deficits in Alzheimer disease. Alzheimer Disease and Associated Disorders. 10: 68-76. PMID 8727167 DOI: 10.1097/00002093-199601020-00003  0.483
1996 Stern Y, Liu X, Albert M, Brandt J, Jacobs DM, Del Castillo-Castaneda C, Marder K, Bell K, Sano M, Bylsma F, Lafleche G, Tsai WY. Application of a growth curve approach to modeling the progression of Alzheimer's disease. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 51: M179-84. PMID 8681001 DOI: 10.1093/Gerona/51A.4.M179  0.409
1995 Albert MS, Jones K, Savage CR, Berkman L, Seeman T, Blazer D, Rowe JW. Predictors of cognitive change in older persons: MacArthur studies of successful aging. Psychology and Aging. 10: 578-89. PMID 8749585 DOI: 10.1037//0882-7974.10.4.578  0.368
1995 Stern Y, Albert M, Brandt J, Jacobs DM, Tang MX, Marder K, Bell K, Sano M, Devanand DP, Bylsma F. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study. Neurology. 44: 2300-7. PMID 7991116 DOI: 10.1212/Wnl.44.12.2300  0.424
1995 Marder K, Richards M, Bello J, Bell K, Sano M, Miller L, Folstein M, Albert M, Stern Y. Clinical correlates of Alzheimer's disease with and without silent radiographic abnormalities. Archives of Neurology. 52: 146-51. PMID 7848122 DOI: 10.1001/Archneur.1995.00540260050015  0.405
1995 Albert MS. How does education affect cognitive function? Annals of Epidemiology. 5: 76-8. PMID 7728289 DOI: 10.1016/1047-2797(94)00044-T  0.329
1995 Hebert LE, Scherr PA, Beckett LA, Albert MS, Pilgrim DM, Chown MJ, Funkenstein HH, Evans DA. Age-specific incidence of Alzheimer's disease in a community population. Jama. 273: 1354-9. PMID 7715060 DOI: 10.1001/Jama.1995.03520410048025  0.375
1995 Duffy FH, McAnulty GB, Albert MS. Temporoparietal electrophysiological differences characterize patients with Alzheimer's disease: a split-half replication study. Cerebral Cortex (New York, N.Y. : 1991). 5: 215-21. PMID 7613077 DOI: 10.1093/Cercor/5.3.215  0.442
1995 Cook NR, Albert MS, Berkman LF, Blazer D, Taylor JO, Hennekens CH. Interrelationships of peak expiratory flow rate with physical and cognitive function in the elderly: MacArthur Foundation studies of aging. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 50: M317-23. PMID 7583803 DOI: 10.1093/Gerona/50A.6.M317  0.373
1995 Sano M, Devanand DP, Richards M, Miller LW, Marder K, Bell K, Dooneief G, Bylsma FW, Lafleche G, Albert M. A standardized technique for establishing onset and duration of symptoms of Alzheimer's disease. Archives of Neurology. 52: 961-6. PMID 7575223 DOI: 10.1001/Archneur.1995.00540340045012  0.385
1995 Lafleche G, Albert MS. Executive function deficits in mild Alzheimer's disease. Neuropsychology (Journal). 9: 313-320. DOI: 10.1037/0894-4105.9.3.313  0.404
1995 Albert MS. Aging, dementia and memory Journal of the Neurological Sciences. 134: 4. DOI: 10.1016/0022-510X(96)80081-5  0.332
1994 Seeman TE, Charpentier PA, Berkman LF, Tinetti ME, Guralnik JM, Albert M, Blazer D, Rowe JW. Predicting Changes in Physical Performance in a High-Functioning Elderly Cohort: MacArthur Studies of Successful Aging The Journals of Gerontology. 49. PMID 8169338 DOI: 10.1093/Geronj/49.3.M97  0.306
1994 Stern Y, Albert SM, Sano M, Richards M, Miller L, Folstein M, Albert M, Bylsma FW, Lafleche G. Assessing patient dependence in Alzheimer's disease. Journal of Gerontology. 49: M216-22. PMID 8056940 DOI: 10.1093/Geronj/49.5.M216  0.454
1994 Jacobs D, Sano M, Marder K, Bell K, Bylsma F, Lafleche G, Albert M, Brandt J, Stern Y. Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology. 44: 1215-20. PMID 8035918 DOI: 10.1212/Wnl.44.7.1215  0.468
1994 Odenheimer GL, Beaudet M, Jette AM, Albert MS, Grande L, Minaker KL. Performance-based driving evaluation of the elderly driver: safety, reliability, and validity. Journal of Gerontology. 49: M153-9. PMID 8014389 DOI: 10.1093/Geronj/49.4.M153  0.36
1994 Blacker D, Albert MS, Bassett SS, Go RC, Harrell LE, Folstein MF. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative. Archives of Neurology. 51: 1198-204. PMID 7986174 DOI: 10.1001/Archneur.1994.00540240042014  0.387
1994 Killiany RJ, Moss MB, Albert MS. Discriminant Analysis of Alzheimer's Disease-Reply Archives of Neurology. 51: 1088-1089. DOI: 10.1001/Archneur.1994.00540230026007  0.395
1993 Herbert LE, Scherr PA, Beckett LA, Albert MS, Rosner B, Taylor JO, Evans DA. Relation of smoking and low-to-moderate alcohol consumption to change in cognitive function: a longitudinal study in a defined community of older persons. American Journal of Epidemiology. 137: 881-91. PMID 8484379 DOI: 10.1093/Oxfordjournals.Aje.A116749  0.322
1993 Richards M, Folstein M, Albert M, Miller L, Bylsma F, Lafleche G, Marder K, Bell K, Sano M, Devanand D. Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"). II. Neurological, psychiatric, and demographic influences on baseline measures of disease severity. Alzheimer Disease and Associated Disorders. 7: 22-32. PMID 8481223 DOI: 10.1097/00002093-199307010-00003  0.325
1993 Albert M, Jenike M, Nixon R, Nobel K. Thyrotropin response to thyrotropin-releasing hormone in patients with dementia of the Alzheimer type. Biological Psychiatry. 33: 267-71. PMID 8471680 DOI: 10.1016/0006-3223(93)90293-M  0.315
1993 Funkenstein HH, Albert MS, Cook NR, West CG, Scherr PA, Chown MJ, Pilgrim D, Evans DA. Extrapyramidal signs and other neurologic findings in clinically diagnosed Alzheimer's disease. A community-based study. Archives of Neurology. 50: 51-6. PMID 8418800 DOI: 10.1001/Archneur.1993.00540010045016  0.449
1993 Berkman LF, Seeman TE, Albert M, Blazer D, Kahn R, Mohs R, Finch C, Schneider E, Cotman C, McClearn G, Nesselroade J, Featherman D, Garmezy N, McKhann G, Brim G, et al. High, usual and impaired functioning in community-dwelling older men and women: Findings from the MacArthur Foundation Research Network on successful aging Journal of Clinical Epidemiology. 46: 1129-1140. PMID 8410098 DOI: 10.1016/0895-4356(93)90112-E  0.35
1993 Killiany RJ, Moss MB, Albert MS, Sandor T, Tieman J, Jolesz F. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Archives of Neurology. 50: 949-54. PMID 8363449 DOI: 10.1001/Archneur.1993.00540090052010  0.452
1993 Duffy FH, McAnulty GB, Jones K, Als H, Albert M. Brain electrical correlates of psychological measures: Strategies and problems Brain Topography. 5: 399-412. PMID 8357715 DOI: 10.1007/Bf01128698  0.332
1993 Inouye SK, Albert MS, Mohs R, Sun K, Berkman LF. Cognitive performance in a high-functioning community-dwelling elderly population. Journal of Gerontology. 48: M146-51. PMID 8315227 DOI: 10.1093/Geronj/48.4.M146  0.39
1993 Evans DA, Beckett LA, Albert MS, Hebert LE, Scherr PA, Funkenstein HH, Taylor JO. Level of education and change in cognitive function in a community population of older persons. Annals of Epidemiology. 3: 71-7. PMID 8287159 DOI: 10.1016/1047-2797(93)90012-S  0.367
1993 Seeman TE, Rodin J, Albert M. Self-efficacy and cognitive performance in high-functioning older individuals: MacArthur studies of successful aging Journal of Aging and Health. 5: 455-474. DOI: 10.1177/089826439300500403  0.35
1992 Albert M, Cohen C. The Test for Severe Impairment: An Instrument for the Assessment of Patients with Severe Cognitive Dysfunction Journal of the American Geriatrics Society. 40: 449-453. PMID 1634695 DOI: 10.1111/J.1532-5415.1992.Tb02009.X  0.37
1992 Sandor T, Jolesz F, Tieman J, Kikinis R, Jones K, Albert M. Comparative analysis of computed tomographic and magnetic resonance imaging scans in Alzheimer patients and controls. Archives of Neurology. 49: 381-4. PMID 1558519 DOI: 10.1001/Archneur.1992.00530280069024  0.308
1992 Hebert LE, Scherr PA, Beckett LA, Funkenstein HH, Albert MS, Chown MJ, Evans DA. Relation of smoking and alcohol consumption to incident Alzheimer's disease. American Journal of Epidemiology. 135: 347-55. PMID 1550089 DOI: 10.1093/Oxfordjournals.Aje.A116296  0.356
1992 Davis PC, Gray L, Albert M, Wilkinson W, Hughes J, Heyman A, Gado M, Kumar AJ, Destian S, Lee C, Duvall E, Kido D, Nelson MJ, Bello J, Weathers S, et al. The Consortium to Establish a Registry for Alzheimer's disease (CERAD) Part III. Reliability of a standardized MRI evaluation of Alzheimer's disease Neurology. 42: 1676-1680. PMID 1513454 DOI: 10.1212/Wnl.42.9.1676  0.427
1992 Duffy FH, Jones K, Bartels P, McAnulty G, Albert M. Unrestricted principal components analysis of brain electrical activity: Issues of data dimensionality, artifact, and utility Brain Topography. 4: 291-307. PMID 1510873 DOI: 10.1007/Bf01135567  0.303
1991 Albert MS, Lafleche G. Neuroimaging in Alzheimer's disease. The Psychiatric Clinics of North America. 14: 443-59. PMID 2062727 DOI: 10.1016/S0193-953X(18)30317-4  0.329
1991 Albert M, Smith LA, Scherr PA, Taylor JO, Evans DA, Funkenstein HH. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. International Journal of Neuroscience. 57: 167-178. PMID 1938160 DOI: 10.3109/00207459109150691  0.468
1991 Albert MS, Cohen C, Koff E. Perception of affect in patients with dementia of the Alzheimer type. Archives of Neurology. 48: 791-5. PMID 1898252 DOI: 10.1001/Archneur.1991.00530200027013  0.38
1991 Evans DA, Smith LA, Scherr PA, Albert MS, Funkenstein HH, Hebert LE. Risk of death from Alzheimer's disease in a community population of older persons. American Journal of Epidemiology. 134: 403-12. PMID 1877601 DOI: 10.1093/Oxfordjournals.Aje.A116102  0.457
1991 Jones KJ, Albert MS, Duffy FH, Hyde MR, Naeser M, Aldwin C. Modeling age using cognitive, psychosocial and physiological variables: the Boston Normative Aging Study. Experimental Aging Research. 17: 227-42. PMID 1820288 DOI: 10.1080/03610739108253900  0.358
1990 Albert MS, Duffy FH, McAnulty GB. Electrophysiologic comparisons between two groups of patients with Alzheimer's disease. Archives of Neurology. 47: 857-63. PMID 2375691 DOI: 10.1001/Archneur.1990.00530080039008  0.396
1990 Albert MS, Wolfe J, Lafleche G. Differences in abstraction ability with age. Psychology and Aging. 5: 94-100. PMID 2317307 DOI: 10.1037//0882-7974.5.1.94  0.304
1990 Jenike MA, Albert MS, Baer L. Oral physostigmine as treatment for dementia of the Alzheimer type: a long-term outpatient trial. Alzheimer Disease and Associated Disorders. 4: 226-31. PMID 2264980 DOI: 10.1097/00002093-199040400-00004  0.337
1990 Jenike MA, Albert M, Baer L, Gunther J. Oral physostigmine as treatment for primary degenerative dementia: a double-blind placebo-controlled inpatient trial. Journal of Geriatric Psychiatry and Neurology. 3: 13-16. PMID 2189429 DOI: 10.1177/089198879000300104  0.373
1990 Evans DA, Funkenstein HH, Cook NR, Hennekens CH, Taylor JO, Albert MS, Scherr PA, Chown MJ, Hebert LE. The Presence of Alzheimer's Disease in a Community Population-Reply Jama. 263: 2448-2449. DOI: 10.1001/Jama.1990.03440180045023  0.392
1989 Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. Jama. 262: 2551-6. PMID 2810583 DOI: 10.1001/Jama.1989.03430180093036  0.415
1989 Milberg W, Albert M. Cognitive differences between patients with progressive supranuclear palsy and Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology. 11: 605-14. PMID 2808652 DOI: 10.1080/01688638908400919  0.445
1989 Albert M, Milberg W. Semantic processing in patients with Alzheimer's disease. Brain and Language. 37: 163-71. PMID 2752272 DOI: 10.1016/0093-934X(89)90106-5  0.361
1988 Scherr PA, Albert MS, Funkenstein HH, Cook NR, Hennekens CH, Branch LG, White LR, Taylor JO, Evans DA. Correlates of cognitive function in an elderly community population. American Journal of Epidemiology. 128: 1084-101. PMID 3189282 DOI: 10.1093/Oxfordjournals.Aje.A115051  0.372
1987 Mayeux R, Albert M, Jenike M. Physostigmine‐induced myoclonus in Alzheimer's disease Neurology. 37: 345-345. PMID 3808321 DOI: 10.1212/Wnl.37.2.345  0.327
1987 Duffy FH, McAnulty G, Albert M, Durwen H, Weintraub S. Lecithin: absence of neurophysiologic effect in Alzheimer's disease by EEG topography. Neurology. 37: 1015-9. PMID 3587619 DOI: 10.1212/Wnl.37.6.1015  0.319
1986 LeMay M, Stafford JL, Sandor T, Albert M, Haykal H, Zamani A. Statistical assessment of perceptual CT scan ratings in patients with Alzheimer type dementia. Journal of Computer Assisted Tomography. 10: 802-9. PMID 3489017 DOI: 10.1097/00004728-198609000-00018  0.382
1986 Moss MB, Albert MS, Butters N, Payne M. Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome. Archives of Neurology. 43: 239-46. PMID 2936323 DOI: 10.1001/Archneur.1986.00520030031008  0.414
1985 Holman BL, Gibson RE, Hill TC, Eckelman WC, Albert M, Reba RC. Muscarinic Acetylcholine Receptors in Alzheimer's Disease: In Vivo Imaging With Iodine 123—Labeled 3-Quinuclidinyl-4-Iodobenzilate and Emission Tomography Jama: the Journal of the American Medical Association. 254: 3063-3066. DOI: 10.1001/Jama.1985.03360210079035  0.331
1984 Jenike MA, Albert MS. The dexamethasone suppression test in patients with presenile and senile dementia of the Alzheimer's type. Journal of the American Geriatrics Society. 32: 441-4. PMID 6725805 DOI: 10.1111/J.1532-5415.1984.Tb02220.X  0.417
1984 Albert M. Assessment of cognitive function in the elderly Psychosomatics. 25: 310-313, 316. PMID 6718665 DOI: 10.1016/S0033-3182(84)73048-9  0.383
1984 Vitaliano PP, Breen AR, Albert MS, Russo J, Prinz PN. Memory, attention, and functional status in community-residing Alzheimer type dementia patients and optimally healthy aged individuals. Journal of Gerontology. 39: 58-64. PMID 6690588 DOI: 10.1093/Geronj/39.1.58  0.31
1984 Vitaliano PP, Breen AR, Russo J, Albert M, Vitiello MV, Prinz PN. The clinical utility of the dementia rating scale for assessing Alzheimer patients. Journal of Chronic Diseases. 37: 743-53. PMID 6501546 DOI: 10.1016/0021-9681(84)90043-2  0.411
1984 Albert M, Naeser MA, Levine HL, Garvey AJ. CT density numbers in patients with senile dementia of the Alzheimer's type. Archives of Neurology. 41: 1264-9. PMID 6497730 DOI: 10.1001/Archneur.1984.04050230046016  0.35
1984 Albert M, Naeser MA, Levine HL, Garvey AJ. Ventricular size in patients with presenile dementia of the Alzheimer's type. Archives of Neurology. 41: 1258-63. PMID 6497729 DOI: 10.1001/Archneur.1984.04050230040015  0.384
1984 Duffy FH, Albert MS, McAnulty G. Brain electrical activity in patients with presenile and senile dementia of the Alzheimer type. Annals of Neurology. 16: 439-48. PMID 6497353 DOI: 10.1002/Ana.410160404  0.384
1983 Weintraub S, Mesulam MM, Auty R, Baratz R, Cholakos BN, Kapust L, Ransil B, Tellers JG, Albert MS, LoCastro S, Moss M. Lecithin in the treatment of Alzheimer's disease. Archives of Neurology. 40: 527-8. PMID 6347143 DOI: 10.1001/Archneur.1983.04210070067022  0.538
1983 Butters N, Albert MS, Sax DS, Miliotis P, Nagode J, Sterste A. The effect of verbal mediators on the pictorial memory of brain-damaged patients. Neuropsychologia. 21: 307-23. PMID 6225962 DOI: 10.1016/0028-3932(83)90018-0  0.363
1981 Albert MS, Butters N, Brandt J. Development of remote memory loss in patients with Huntington's disease. Journal of Clinical Neuropsychology. 3: 1-12. PMID 6456280 DOI: 10.1080/01688638108403109  0.339
1981 Albert MS, Butters N, Brandt J. Patterns of remote memory in amnesic and demented patients. Archives of Neurology. 38: 495-500. PMID 6454407 DOI: 10.1001/Archneur.1981.00510080057008  0.315
Show low-probability matches.